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ABSTRACT
Monocytes and tissue macrophages play important roles 
in hosv defence against viru'*. infections and can 
respond to infections by secretion of inflammatory 
mediators. The effect of HCMV infection on monocyte 
cytokine production was therefore studied at functional 
and molecular levels. This study primarily investigated 
the influence of H O  > infection on 1L-16 production and 
expression in peripheral blood monocytes and the 
promyelocytic cell line, ML-3. The expression of 
several other inflammatory response genes, TNF« ,
CSF-1, MAD-2, HAD-6 and V.: *1-9 was investigated in ML-3 
cells. LPS-stimulated and unstimulated monocytes 
infected with a clinical isolate of HCMV showed 
expression of HCMV IE antigens and were significantly 
more suppressive for lymphocyte proliferation than were 
strain AD169-inf<?cted monocytes, which rarely expressed 
detectable HCMV IE viral antigens. HCMV infection of 
LPS-stimulated and unstimulated monocytes resulted in 
abrogation of functional 1L-1 bioactivity, with the 
effect being marked in LPS-stimulated monocytes 
infected with the clinical isolate of HCMV. Addition of 
IL-1 to infected, stimulated monocytes completely 
restored lymphoproliferative responses to PHA, whereas 
addition of this monokine to infected, unstimulated 
cells could not restore .'his response. At the level of 
IL-18 steady atmt* mRNA expte*sion, both RNA Jot-blot
xl
and iti situ hybridization studies demonstrated that 
infection of monocytes with HCMV lead to sustained 
expression of IL-18 mRNA for up to 98 hr, which 
contrasted markedly with mock-infected or 
LPS-stimulated monocytes. Exposure of ML-3 cells to 
virus prior to induction of differentiation had little 
influence on mediator gene expression. However, 
induction of the macrophage phenotype by pretreatment 
of ML-3 cells with the phorbol ester, PMA, followed by 
HCKV challenge resulted in a greatly extended period of 
expression of IL _B , TMF a, *.AD-9 and CSP-1 but not 
MaD-6 and MAD-2. Constitutively expressed genes such as 
lysozyme anf actin were not similarly modulated. Plow 
cytometric analysis of the intracellular levels of IL-1S 
protein in ML-3 cells indicated that more protein was 
produced in infected cells than in uninfected controls. 
Enhanced levels of the intracellular form of IL-1B in 
monocytes was confirmed by Western blot analyst. 
Cotransfection experiments were performed using IL-1B 
-CAT chimeric plasmids together with plasmids encoding 
HCMV IB gene region products. Transactivation of the 
IL-18 gene by region 2 of the IE gene was observed in 
ML-3 cells that had been induced to differentiate prior 
to transfection. Me stimulation of IL-10 promoter 
activity was observed in ML-3 cells that were 
undifferentiated prior to transfection.
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11.0.0. INTRODUCTION
1.1.0. General characteristics of the cytomegalovirus 
{CMv) group
The family of Herpesviridae is divided into three 
subfamilies consisting of the herpes simplex viruses 
(Alphaherpesvirinae), the cytomegaloviruses 
(Betaherpesvirinae) and the lymphoproliferative virus 
groups (Gammaherpesvirinae). Each subfamily has been 
taxonomically named according to its biological 
properties (Roizman, 1982).
Human herpesvirus 6 (HHV-6) is a new herpesvirus, 
antigenlcally distinct from other human herpesviruses 
and has been isolated recently from peripheral blood 
lymphocytes of patients with the acquired 
immunodeficiency syndrome (AIDS) (Lopez et al., 1988? 
Tedder et al., 1987), from patients with 
ly mphoproliferative disorders (Salahuddin et al., 1936) 
and from infants with exanthem subitum (Yamanishi et 
al., 1988).
The main characteristics of the cytomegalovirus (CMV) 
group are the following (Mathews, 1979)$
1) The complete virion is 150 to 200 nm in diameter.
zand consists of an inner core, a capsid and an 
envelope. The core contains the DMA genome which has 
a molecular weight of 150 x 10* with a G + C ratio 
of 50%. The virus nucleocapsiC is an icosihedrvn <90 
to llOnm) consisting of 162 capsomer* subunits. The 
capsid is surrounded by the tegument which is 
enclosed by a lipid bilayer envelope,
2) The reproductive cycle is slow {>24 hr) and is 
characterised by slowly forming progressing foci in 
cell culture and enlargement of the infected cell in 
vivo and in vitro (cytomegalia). inclusion bodies 
containing PNfc may be present in the nuclei and 
cytoplasm late in infection.
3) Mouse cytomegalovirus (MCMV) persists in the 
salivary glands of mice and can also latently infect 
mouse macrophages (Brautigam et al., 1979). The site 
of human cytomegalovirus (HCMV) persistence is much 
less certain. Epithelial cells in salivarv glands 
and renal tubules have been suggested as possible 
sites (Sissons et al., 1986).
4) CNV displays strong species and cell specificity, in 
cell culture, the virus usually grows best in 
fibroblasts of '-he species from which it was 
originally isolated, but exceptions do exist.
31.1.1, Medical Importance
The genus human cytomegalovirus (HCMV) is recognised ai> 
an important pathogen.The incidence of HCMV infection 
of humans is high, but most postnatal infections are 
acquired without clinical symptoms (Huang and Pagano, 
1977). During their lifetime, 60 - 80% of individuals 
in developed countries and almost 100% in developing 
countries became infected with HCMV (Peckham et al.,
1983 j Griffiths et al., 19-85). After primary HCMV 
infection in vivo, the virus often establishes a latent 
existence which is clinically important (Diosi et al., 
1969). The severe diseases caused by HCMV frequently 
result from reactivation of latent virus, and are 
usually associated with immunosuppression due to a 
variety of conditions such as malignant disease, 
chemotherapy, organ transplantation (Ho, 1982) and the 
acquired immunodeficiency syndrome (AIDS) (Drew et. al., 
1985). HCMV is the causative agent off a wide variety of 
diseases ranging from the classi.cLl cytomegalic 
inclusion disease to intrauterine d th, prematurity, 
congenital defects, infectious mononucleosis, 
postperfusion syndrome, and interstitial pneumonia in 
transplant patients (R»pp, 1980? Weller, 1971). In 
kidney, bone marrow or heart transplant pacients and 
patients with malignancies or connective tissue disease 
who are maintained on immunossupressive agents, HCMV
4infection is commonly associated with organ rejection 
or loss. Infection also contributes to mortality and 
predisposes these patients to severe or fatal 
bacterial, fungal and parasitic infections by causing 
further immunosuppression.
Drug therapy of herpesviruses has recently advanced 
with the development of nucleoside analogs that are 
active only in herpesvirus infected cells (Biron et 
al., 1985). The most recent therapy has used 
ganciclovir, an acyclovir analogue, that is active 
against HCMV and all herpes viruses (War et al., 1983). 
The mechanism of action has not been fully elucidated 
but appears to be due to the selective phosphorylation 
of the drug to ganciclovir triphosphate in KCMV 
infected cells but not in uninfected cells (Biron et 
al., 1985). It is a more potent inhibitor of HCilV in 
vitro than acyclovir and has exerted an antiviral 
effect against HCMV in bone marrow and organ transplant 
recipients (Brice et al., 1987). It has also been used 
in clinical trials in patients with AIDS who have 
serious HCMV infection (Laskir. et al., 1987). Clinical 
trials have also used vidaribine monohydrate (Meyers et 
si., 1382), acyclovir (Wade et al., 1982 i Balfour et 
al., 1982), interferon (Meyers et al., 1980) or 
comb ations of these various agents (Shepp et al.,
1984). However, none of these agents has exerted the 
same antiviral effect as that shown by ganciclovir.
*The prevention of prlaat* lafeetlon by mean# of 
vecclnetl nre#*m#b$y depomd on entlbody
recogniz inin# 6#tormio#nt* on the virion
(Sieeone e^ Tb# moot eultnblo vooeine would
be e eubunit v. # o* U w o  hC#f ne # vaccine hea
been reported by ' Tbete ere
however nuneroue drewi wbe to tble type of recoine. The 
extent of attenuation 01 the attaint le uncertain, ae 
well as the biological |-n 'artlea and ability to 
establish latency.
In addition to the clinical manifestations mentioned, 
HCMV nee been Implicated with malignant disease by 
virtue of its ability to trameform cella vitro and 
the trading of HCMV Dbh, W h  and virue a pacific 
antigens associated with Repeal's sarcoma, prostatic 
adenocarcinoma, cervical and colon cancers (Huang at 
al., 1984). These findings have more recently been 
substantiated by Fletcher (1986) who have
detected restriction endonuclease sites eolinear with 
virion dna in a email percentage of histologically 
abnormal cervices. Morphological transformation studies 
have failed to demonstrate a vital oncogene, a virus - 
coded transforming protein or any sequence of DMA that 
uniquely transforms cells according to "one - hit" 
kinetics. The transformed cells are however all 
oncogenic in the host animal and in Immunocompromised
6mice (Macnab, 1987). Tranafotming domains among the 
herpesviruses have been localised in small DMA 
fragments (Nelson et aL, 1984; Galloway et al., 1984) 
and have stem/loop structures bounded by direct 
repeats. The morphological transforming region of BCMV 
DMA imtr) consists of three regions mtrl. mttn and 
atrlll which have been mapped in the long unique region 
of t ie viral genome. Rezzaque et al. (1988) have 
identified tie mtrll of BCMV. In view of the 
transcriptional control signals and stem/loop 
structures that have been identified in mtr II, it is 
possible that mtr II transforms cells by increasing the 
transcription of critical cellular genes or may induce 
transformation by altering the structure of host DMA 
through fusion and gene rearrangement (Jariwalla et 
al., 1986 ; Bejeck and Conley, 1986). Molecular studies 
have also suggested a role for BCMV in carcinogenesis. 
The major enhancer of BCMV increases transcription of 
cellular genes (Boshart et al.. 1985! which may be of 
great importance in cell behaviour during the 
progression of carcinogenesis.
1.1.2. Structure of BCMV
1.1.2.1. DMA of BCMV
7The 8CMV genome consists of doubla stranded DNA with a 
molecular weight of 150-155 x 10®. It Is a linear 
molecule consisting of a long unique (L) and a short 
unique (S) component which are covalently linked 
(Figure 1). Each component may be inverted which gives 
four different isomeric arrangements of the molecule.
The L and s components are flanked by different repeat 
sequences that are inverted relative to each other 
(Stinski et al., 1981). The biological significance of 
this DMA structure is unknown. A number of strains of 
HCMV have been isolated including the Davis, Esp, Kerr 
Towns and AD1S9 strains. The commonly used laboratory 
strains of HCMV (A0169, Towns and C87) had 
approximately 80% genome homology when analysed by 
nucleic acid reassociation kinetics (Huang et al.,
1976).
1.1.2.2. structural Proteins of HCMV
O
J
Many o' the structure! proteins of HCMV have been 
determined using chemical denaturatlon of virions 
purified by physical methods (Gibson, 1983; Irmiere and 
Gibson 1983) (Table 1). More recently. Wright et al. 
(1988) have Identified the ptoteins encoded by the 2.2 
kb early transcript of AD169. The proteins were 
phosphorylated and had molecular weights of 84K, 50K, 
43K and 34K. They were associated predominantly with 
the nuclei of infected cells.
:
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Figure 1 Schematic representation of the HCMV genome and 1E plasmid
constructs (after Davis ef a/., 1987).
(a) Fractional length of the HCMV genome
(b) Plasmid pHDIOISVI. Plasmid sequence"' derived from 
pBR 322 (open box) and RNA transcripts corresponding to 
HCMV 1E regions 1 and 2 (closed boxes) are shown right to 
left
(c) Plasmid pHD101SV2. The Sa/n HI fragmentfrom region 2 of 
pHDIOISVI has been deleted to form pHD101SV2.
(d) Plasmid pHDl014. The Oam HI fragment from region 2 of 
pHDIOISVI was Inserted downstream from e Tayl frag­
ment containing the promoter and first three exons «. f IE  
region 1.
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Table 1 Major Structural proteins of virus particles
Three distinct families of disulphide-linked 
llycopcotein complexes have been observed in the 
envelops of HC*V and have been designated gel, gcll and 
gclll (Gretch et al., 1988). The three complexes ace 
almost certainly important targets cf human 
response to HCMV infection (Gretch ejt al., 1988). The 
gel complex contains the gp55 gene product which has 
amino acid sequence homology with RSV gB, EBV gB, VZV 
(varicella zoster virus) gpll and pseudorabies virus 
gpll suggesting that the gel family may play a role in 
the fusion of viral and cellular membranes. Functional 
roles for gcll and gclll have not yet been assigned.
Each protein of HCMV will ultimately be identified as 
a, gory , being derived from a 43, or ^primary genomic 
transcripts respectively. Most of the structural 
proteins are classif ied as y . Examples of 8 p "steins 
ace the virion DNA polymerase, the 5GK phosphorylated 
ONA-binding protein (Gibson, 1983) and the 14GK 
non-phosphorylated protein which binds single-stranded 
DNA (Anders et al., 1986). The most prominent a protein 
is phosphorylated and has a molecular weight of between 
70 KDa and 79 KOa (Michelsor.-Fiske et al., 1977;
Stinski et a_l., 1983).
The assembly of proteins to form progressively more 
mature A,B and C capsids is shown in Figure 2. Two 
morphological forms other than virions can be 
identified when HCMV is passaged in coll culture. One
GOLGI
dense body
yNlEP
virion
CYTOPLASM
153000
36000
69000
7400028000 34000
DMA
A —  caps#
36000NUCLEUS
Figure 2
Schematic outline of assembly of C M V  particles 
(after Griffiths and Grundy, 1987)
Numbers represent the M r of identified proteins
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is the derss body, which is much larger (300 nm) and 
more pleomorphic than the virion. More than 90% e£ its 
protein is the 69 KDa matrix protein together with 
envelope glycoprotein (Irmiere and Gibson, 1983). Dense 
bodies do not contain nucleic acid or a nucleocapsid.
Tne second form is known as a non-infectious enveloped 
particle (NIEP) which resembles a virion without a 
central core containing DNA. The NIEP is thought to be 
an enveloped B capsid containing an excess of the 36K 
assembly protein.
1.1.3. Regulation of riCMV Gene Expression
HCMV undergoes a sequential order of gene expression m  
permissively infected cells (McDonough and Jpector,
1983 , Wathen and Stinski, 1982). The first genes to be 
expressed are the a or immediate-early (IE) genes 
(Figure 1) which can be transcribed, in the absence of 
de novo protein synthesis (McDonough and Spector, 1983 
? Stinski et al., 1983 ; Wilkinson et al., 1984). The 
products of the 3 genes are those the virus requires 
to take over control of host cell macromolecule 
synthesis (Griffiths and Grundy, 1987), The majc site 
of IE transcription for AD169 and Towne is located in 
the long unique segment (Stinski et al., 1983), is 
mapped at coordinates 0.71 to 0.75 (Figure 1) and 
encodes at least three transcription units designat d 
IE1, IE2 and IS3 (Wathen and Stinski, 1982 ; Stenberg 
et al.# 1984). A fourth IE transcription unit
14
initiating in this region specifies a 5 kb RNA vJahn et 
al„ 1984).
IE1 encodes a 72 kDa nuclear phosphoprotein (Stinski et 
al., 1983 ; Stenberg et al,» 1984) and is efficiently 
expressed following either Infection or transfection of 
the isolated gene into tissue culture cells. The 
expression is mediated via a strong enhancer element 
consisting of different subsets of repeats that can 
independently substitute for enhancer activity (Boshart 
et al., 1985 • Stinski and Roehr, 1985). An HCMV 
component further enhances IB gene expression in trans 
via these repeat sequences (Stinski and Roehr, 1985).
IE2 is iit.mediately downstream of IE1 and consists of 
two subregions IE2a and lE2b (Hermiston et al., 1987). 
Transcription is highly complex with different 
transcripts being produced as a result of differential 
mRNA splicing. Predominant transcripts consist of all 
four exons of IE1 but there are also transcripts 
consisting of the first three exons of IE1 linked to 
IE2a (Hermiston et al., 1987).
An important phenomenon that has been observed in the 
infection of nonpermissive cells is the expression of a 
and 6 genes only. Transcription of the late genes is 
blocked. This has been shown in human monocytes and 
lymphocytes acter in vitro infection (Rice et al.,
1984? Einhorn and Ost,
15
Early or 8 genes (Figure 1) are transcribed before the 
onset of viral DNA replication and their transcription 
requires prior expression of one or more of the 
genes. Products of the B genes are required to control 
production of daughter virions (Griffiths and Grundy, 
1987). The mechanism of this activation as well as the 
cis-acting elements of the BCMV early genes responsible 
for that temporal regulation have not yet been fully 
elucidated (Staprans et al., 1988). These investigators 
have shown thus far chat the HCMV major IE region can 
trans-activate the 2.2 kb early RNA promoter. Further 
studies will determine if additional viral or cellular 
factors are involved in the regulation of HCMV 2.2 kb 
early RNA transcription.
The y or late genes (Figure 1) code for the structural 
components of the virion (Griffiths and Grundy, 1987). 
Geballe et al. (1986) have shown that expression of the 
late genes is controlled by post-transcriptional 
events. Two late genes encoding infected cell protein 
(ICP)27 and ICP36 are transcriptionally active at early 
times U h  post infection) but their expression is 
delays). This may depend on post-transcriptional 
influe ces such as transcript transport to the 
cytoplasm, transcript accumulation, differential 
polysome association or differential stability of mRNA.
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1.1.4. Trans-activation by the HCMV Immediate-Early 
Gene Products
The region of the HCMV genome which reportedly 
activates heterologous promoters in transient assays is 
the Hind III B fragment for strain AD169 and Xba I E 
fragment for the Towne strain (Everett, 1984). This 
region of the genome has at least four transcription 
units within approximately 20 kb (Stinski @t al.,
1983), Three of these units are positioned down stream 
of the major IE promoter regulatory region which 
contains cis-acting enhancer elements (Boshart at al., 
1985/ Stinski and Roehr, 1985 ). These HCMV genes have 
been designated IE1, IE2 and IE3 (Stinski et al.,1983).
It has been postulated that one or more of these genes 
may function to regulate HCMV by stimulating 
transcription from vir*I and other promoters. Numerous 
studies have proposed thac IE1 might be responsible for 
this function (Everett. 1984/ Spector and Tevethia, 
1986; Stinski et al., 1983). However, IE1 is expressed 
at a much higher level than is necessary for most 
trans-acting proteins, and reaches maximum levels 5-6 
hrs after infection, long before extensive 
transcription of the genome begins. When tested in 
permissive cells, the 1 11 gene product had little 
stimulating effect on the adenovirus E2-inducible 
promote; (Hermiston et al., 1987). IE2, however, is
17
made at levels more consistent with its role aa a 
r*gul*tory protein and raacb*# * maximum 1#*#1 of
transcription 48 to 72 hr postinfection, when viral 
gene expression is at its highest Wathen and Stinski, 
1982). It has been found to express a regulatory factor 
that significantly stimulates the adenovirus E2 
promoter as judged by expression of the chloramphenicol 
acetyItransferase (CAT) gene linked to this promoter 
(Bermiston et al„, 1967). There are protein products of 
various sizes associated with IE2. Two ot these of 27 
and 30 kDa coded for by the I12a qene can independently 
stimulate the ed*no"iru= t52 promoter, as judged by CAT 
activity.
Pizfiorno et al.(1988) have also shown that one of the 
phosphorylated nuclear protein# ennodad by the major IE
gene region acts as a powerful but nonspecific 
trans-activator of gene expression. In transient CAT 
assay experiments, the Hind III C fragment of HCM?
Towne strain DMA, encompassing the IE1 end IE: coding
regions (exons 1 to 5), was able to stimulate 
expression from a variety of promoters. These included 
the human beta interferon gene. The 111 coding region 
alone (exons 1 to 4) * as inactive, but trans-activation 
was restored by insertion of the 1E2 coding region 
(exon 5) in the correct orientation downstream from 
IE1.
Davl# #t (1*87) *bo*:«d that th* BCMV IB g*n* region 
#timulat#4 *Kp[*«#lOT. of tb* CAT g*n* linked to th#
human Immunodeficiency virus (HIV) promoter. The HIV 
provlrsl genome has a promoter located within the 5' - 
long terminal repeat (LTR) that is t_rans-activated by 
the HIV - encoded gene tat (trane-activating 
transcriptional activator). Sequences located on the 3' 
side of the mRNA start site termed transcriptional 
activating region (TAR) are necessary for 
trana-activation by tat to occur (Chen, 1986). The HCMV 
IE gene region continued to trans-activate the HIV 
promoter even when the tat-responsive sequence had been 
which «ugg«*t«d that th* HIV ta& and BCMV IE 
region trans-active,ted the HIV promoter using different 
maohariama. It was alao found that the IE region 2 gene 
products could trans-activate the HIV promoter 
Indapand'ntly of the IE region 1 gen* producta.
1.1.5. Replication in Nonpermisalve and Permissive 
Cells of Human Origin and Latency of HCMV
In th* human host HCMV can infect a variety of ceH 
types and presumably enters both nonproductive 
(nonpermlsslve) and productive (permissive) cells.
Sataral studies have propoaad that EC1V early g*ne 
ampraasio.i but not late gan* axpreasion occura in 
nonpcoductiva cells (Moc^rakl and :tinaki,l$7#i Wathen
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et al,, 1981) and that the nonproductive cell may 
fevour latency of th* *lr*l genon*.
HCMV frequently establishes a latent 1nfection after an 
asymptomatic Infection in a healthy individual. It can 
be reactivated, usually in association with 
immunosuppression to cause interstitial pneumonia and 
systemic disease (Ho, 1982). The site of latency and 
th« molecular m*ch»ni*#m of th« «mtabllmhm«nt and 
maintenance of HCMV latency have yet to be determined. 
Seronegative individuals have been infected via blood 
tranafumiona from healthy a*rnpo*itiv* donor* (stavan* 
al., 1*70). Thia haa lad to apaculatlon that 
peripheral blood mononuclear cell a (p#MC) in 
aaymptomntlc In, duala may be a reaevoir for latent 
HCMV. aybridlaation expe.imenta uaing a cDMA probe 
apeclfic for IE tranacripta of HCMV have suggested that 
natural infection in healthy aeropoaitive individuala 
may reault in a low frequency of circulating PBMC that 
expreaa HCMV RMA (Schrier ot !&., 1*95). This finding 
haa aeveral implicationa. Plrat, a populalion of cel'.a 
capable of harbouring HCMV haa been identified. Second, 
the preaence of primarily HCMV IB MM* tranacripta 
Indicatea that virus replication la reatrlcted. 
Tranafualon-medlated tranamlaaloi auggeata that 
infectioua HCMV can be
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reactivated from a lymphoid population. The biological 
mecb i#, remain* unclear.
S. _th (1980 attempted to define the characteristics 
which render a cell permieeiee for BCMV. * number of 
human cell lines differing in morphology, ploidy and 
extent of differentiation were screened. High titre 
HCHV replication occurred in a well-differentiated, 
diploid epithelial c . .1 line derived from normal human 
colonic mmooee. hneuploid cell type* ;ere all 
nonpetmieeivo. Hot all fibroblastic cell lines were 
permlme&ee for 8CWV. When permieaive and uonpermieeive 
cell types were cocultured prior to infection, neither 
cell ypa released soluble mediators capable of 
reeereim# the WCMV eueceptlbll.ty of the other cell 
type.
Beeeral ineeetlgatore have attempted to determine an ig 
vitro WCWV latency model in an attempt to establish 
which cells harbour HCHV in the latent state, the 
mechanisms involved in reactivation and the state of 
the latent genome in persistently infected cells.
Tanaka jjt gjt, (1987) attempted to establish an in vitro 
model using a human epithelial thyroid papillary 
carcinoma cell line (TPC-1). HCHV was reactivated from 
latently Infected TPC-1 cultures by decreasing the 
incubation temperature from *0.5 C to 37 C, with 
cultures subsequently entering into virus perai ent
a
infection. Virus-specific DNA polymerase i an early 
viral protein ) was not induced in latently infected 
TPC-1 cultures, suggesting that the block in 
replication occurred at the early stages. Latently 
infected cells were susceptible to superinfection by 
homologous and heterologous strains of HCMV. I n  
persistently infected cultures, 38% of the cells could 
be lyced by reaction with HCMV immune serum and 
c o m p le m e n t .  Complement-mediated immune cytolysis could 
not be detected in latently infected cultures. T h e i r  
data suggested that a t e m p e r a t u r e  sensitive cellular 
functionis) that controls ths expression of the Q CM V  
early functions plays an important t o l a  i n  the 
maintenance o* the HCMV genome i n  the latent state and 
its reactivation to a persistent infection as a result 
of decreasing the temperature. Suosequent studies by 
Tanaka et al. (1968) have shown that when the latently 
infected cells were treated with indcmethacin or 
tetracaine im m e d i a t e ly  after being shifted to 37 C, 
reactivation of latent virus was not observed. 
Indomethacin and tetracaine ini ibit replication of DNA 
viruses in cells, suggesting a role for ar.chidonic 
metabolites as regulatory agents for productive viral 
infection.
Gonczol et al. (1984, 1985) examined HCMV infected 
human teratocarclnoma cells as a possible latency model 
for HCMV. Undifferentiated cells produced neither
viral antigens or progeny virus. However, treatment 
with retinoic acid allowed for expression of viral 
antigens and release of progeny virus.
LaFemlna and Hayward (1986) localised the block in the 
nonpermissive teratocarcinoma cells as occurring before 
IE protein synthesis and suggested that it occurred at 
the level of IE transcription. After differentiation, 
synthetis of the IE 68K protein was induced and viral 
ON A replication occurred.
1.1.6. HCMV Infection in Normal Hosts
Primary infection Is generalised and portals of entry 
may include blood via blood transfusions, oral or 
orogenital contact or possibly genital contact alone. 
Viraemia is detectable for a few weeks to a 'aw months 
(Alemola, 1973). Th^ polymorphonuclear leukocyte is the 
main source of HCMV in the blood, but monocytes and 
occasionally T lymphocytes may harbour HCMV in a form 
as yet undefined (Carney and Hirsch, 1981; Piala et 
si., 1975; Garnett, 1982; Rinaldo et al., 1977; Rinaldo 
et al., 1979).
Cell-mediated immunity is depressed with symptomatic 
primary infections, with T cell dysfunction being 
prominent (Rinaldo et al., 1977). Peripheral blood
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monocytes in blastogenic assays respond poorly to the 
mitogens concanavalin A and pokeweed mitogen, 
HCMV-specific antigens and other herpesvirus antigens 
during the acute phase cZ HCMV-associated illness 
(Rinaldo et al., 1977). Responsiveness to mitogens and 
heterologous antigens returns before responsiveness to 
HCMV-specific antigens. Cytotoxic/suppressor 
lymphocytes (T8) increase strikingly while the 
helper/inducer subset (T4) cells are slightly 
diminished, resulting in a reversal of the normal ratio 
of these cell types (Carney et al., 1981).
1.1.7. Infection in Immunosuppreased Hosts
Following renal transplantation, reactivation of latent 
infection from the recipient or from the donated 
allograft accounts for most infections (Betts et al.,
1975; Pass et al., 1973). Virus shedding posttransplant 
in individuals who were seropositive prior to 
cranspiar.t is referred to as nonprimary infection and 
shedding and seroconversion is referred to as primary 
infection. Approaches to the prevention of primary HCMV 
infections in transplant recipients have included use 
of seronegative biood products in seronegative patients 
who received marrow transplants from seronegative 
donors (Hersman et al., 1982)., the use of live 
attenuated vaccine i' renal transplant recipients 
(Plot kin et al., 1934), use of HC VV immune plasma
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(Winston et al., 1982) or HCMV immune globulin (Condie 
and O'Heilly, 1984).
Grundy et al_. (1986) used restriction endonuclease
analysis of HCMV isolates to show that HCHV infection 
of a seropositive renal allograft recipient was due to 
a virus from the donor kidney. This finding suggested 
that HCMV infection could behave as a primary infection 
when there was transmission of a viral strain from the 
donor that was different from that of the recipient. 
Rakela et al. (1987) have shown that serology of the 
donor is still the most important factor in predicting 
primary infections, Chou <1987', showed that antigenic 
velatedntss among HCMV strains may detf .\ine it 
reactivation of endogenous strains or reinfection 
occurs in seropositive organ recipients receiving 
transplants from seropositive donors.
HCMV coaaonly infects patients with AIDS and may be an
important co-factor for the full expression of AIDS 
(Draw et al., 1985). More than 95% of homosexual men 
ace seconositive for HCMV and many actively shed iru# 
(Huang et_ al., 1985). Recent observations have shown 
that an elevated Litre of HCMV antibody is a 
significant predictor of t development of AIDS in HIV 
-seropositive individuals iPolk et al., 1987). 
Furthermore, HCMV viremia increases with progressive 
immune deficiency in patients infected with HIV-1 
(Fiala et al., 1986).
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HCMV has the potential toe interacting with HIV at 
molecular and functional levels, thereby contributing 
to progression of the immunodeficiency syndrome (Nelson 
et al., 1988). HCMV-induced immunosuppression (Carney 
and Hirsch, 1981 ; Schcier et al., 1986) may lower the 
imaunocompetence and allow for spread of Hiv. At ».he 
in vivo level, Unison et al. (1988) have shown direct 
interaction between HIV and HCMV. Double labelling 
techniques have shown that HIV and HCMV can coinfect 
central nervous system tissue in AIDS patients. This 
observation, together with the report of Divls et al. 
(1987), that HCMV can increase transcription of HIV in 
vitro, suggest a direct role for HCMV in the 
pathogenesis or AIDS.
Severe bacterial and fungal \ Lections ar^ increased in 
cardiac and renal transplant patients following HCMV 
infection, particularly when it is of the de novo 
primary type (Chatterjee et ul., 1978; Braun and 
Nankervis, 1978?). These investigators have shown tha" 
since the early use ol immunosuppression in transplant 
surgery, infections - in particular wit;. Pseudomrnam 
and otnec Gram-negativ3 bacilli, Nocardia, 
opportunistic fungi and Pneumocystis carinii - were the 
major id: »s of death. Their study showed that 
opporLUT.ict.c fungal infections occured much more 
frequently in renal allograft recipients who tested 
HCMV seronegative prior to transplantation.
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1.!*#*• -;OMiiAgl»on of BCMV Laboratory Strains and 
c u . i c ^  of .CMV
Rica «t aL. (19841 showed that monocytes, natural 
klliar oella and $ and B lymphocytes can be abortively 
infected with SCWV |n vitro, as demonstrated by 
iemunotlourescent staining using monoclonal antibodies 
to BCMV IS antigens, this abortive ip feet ion was most
-V.eMli^ WWWiMMtrable with fresh, low-passage clinical
.
i#oW0#, *be frequency of appearance of I: antigens 
wee iegbb Ikwer when the laboratory adapted attain A0169 
we# $###4 Which euggeated an increased lyaphotroplc 
effect of fresh Isolates of BCMV compared with strains 
of vireh Cbieh were extensively adapted to growth in
nek#. Among PBMC, monocytes comprise the cell
'
l d h h  the greatest proportion of cells 
sa, «## the immediate-early gene product. All 15 
psemeg# i#*l#tee Of BCMV used In the study completely 
abcogmted the mltogenlc response of peripheral blood 
monCCBClemr oella to phytohemagglutlnln (PRA). Tne 
dichotomy i# the behaviour of freshly isolated and 
labotehory mdapted strains of MCMV has been 
corroborated by tinhorn and Oat (1984), who also found 
that M#e«muc:aer cells had a differential tropiam tor 
the different strains of virus. The highest percentage 
of I# ##&!§## poeltiva cells in this study was 
aooocytea. Infected cells remained lE-antlgcn positive 
In ##lh#B# for 7-13 days.
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Restriction site polymorphisms among clinical isolates 
and laboratory strains of HCMV have been compared 
(Chandler and McDougaii, 1986). Tht.je authors compared 
Hind III and Ecc Ri restriction sites in the long and 
shore unique regions of the HCKV genome among 20 low 
pzssage clinical isolates and four laboratory strains. 
Southern blot analysis with a series of subgenomic 
cloned fragments of AD169 was performed. Although no 
two strains were identical throughout the genome, 
identical patterns c-f variation in a given region 
frequently occurred in multiple strains, polymorphisms 
occurred throughout the entire genome, including the 
region coding for immediate-early functions. All 
strains studied showed an identical fragment which 
hybridized to the cellular transforming region of 
AD169. No specific difference which could be related to 
length of time in tissue culture passage w:,s found 
between the laboratory strains and the clinical 
isolates in their study.
The differential tropism that has been observed may be 
an important phenomenon among the heipesviruses. Slxhey 
ot al. (1983) showed that recently isolated strains, 
but not laboratory adapted strains of Bpstein-Bar: 
virus could infect human epithelial cells and that 
viral genomic expression was incomplete in cells 
infected with rec ntly Isolated strains.
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1.3.0 MONONUCLEAR PHAGOCYTES
All mononuclear phagocytes constitute a cell lineage 
that originates jfcom a pluripotent stem cell in the 
bone marrow. The differentiation pathway proceeds 
through the stages of monoblasts, promonocytes, 
monocytes and macrophages (van Furth, 1980). Monoblasts 
and promonocytes are Located in the bone marrow and are 
actively dividing cells that give rise to monocytes. 
Monocytes are transported via peripheral blood to the 
tissues where they become macrophages. Depending on the 
destination tissue site they become histiocytes of 
connective tissue, osteoclasts in bone tissue, Kupffer 
cells in the liver, alveolar macrophages in the lung, 
macrophages of the spleen, lymph nodes and bone marrow 
and free macrophages of the pleural and peritoneal 
cavity. It is becoming more evident that in addition to 
being effectors of non-specific host defenses, 
monocytes also play an impo tant role in the induction 
and modulation of specific immune responses.
Monocytes measure 12 to 15 urn and make up ? .o 8 
percent of peripheral blood leukocytes. The nucleus is 
indented and has a characteristic kidney shape. The 
cytoplasm contains many fine azurophilic granules 
(Nichols et al., 1971). Electron microscopy shows the 
Golgi apparatus of monocytes to be well developed;
lysosomal granules are numerous and mitochondria are 
evenly distributed. Nucleoli are seen in about half the 
cells. Cytochemical studies help identify promonocytes, 
monocytes and macrophages, the latter being positive 
for non-specific esterases (Lam et al„ 1971). 
Macrophages represent a later stage in the development 
and maturation of monocytes. In the transition from 
monocyte to macrophage, there are increases in the 
number of lysosomea, the number of mitochondria, the 
activity of mitochondrial enzymes and the rate of 
cellular respiration.
1.3.1. Monocyte Cell Lines
Studies of macrophage differentiation using primary 
cultured cells ars difficult due to the heterogrneity 
between and within macrophage populations. The highly 
variable state of differentiation that cells of the 
mononuclear phagocyte series may exhibit and the 
influence that this may have on virus exposure and 
latency ate issues that ate presently being addressed. 
For these reasons, monocyte o: macrophage cell lines 
are used in many areas of macrophage research. Of 
special interest are cell lines such as ML-3 and HL-60 
which can be induced to change differentiation states 
in response to stimulation with a variety of chemical 
and biological agents (Harris and Ralph, 1985).
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Th* human promyulocytlc cell lin*, NL-3, uuno in thlm
study is essentially identical to the HL-60 cell line 
established by Collins et al.(1977).
1.3.1.1. phenotype of Onlnduced Pronvelocytic cells
The phenotypic character of HL-60 reflects its xeukemic 
origins. Phenotypically HL-60 resembles blast cells of 
their lineage and are believed to be the neoplastic 
derivatives of commited progenitors of granulocytes and 
monocytes. Histochemistry and morphology of these calls 
typify them as immature cells of the myelomonocyte 
lineage. They have a population doubling time of 24-48 
hr and stain as myeloblasts and promyelocytes, though 
approximately 104 appear to be more mature cells 
(Gallagher et al.. 1979). Cells are characterised 1 y a 
lack of lymphoid markers, growth as compact colonies in 
aemiaolld culture and nonadherence to substrata. Celia 
pommasm few Pc-IgG and C3b receptors and weakly 
phagocytlxe latex or yeast particles. HL-60 cells eleo 
possess receptors for the chemotactlc tripeptldc 
tormy1-methlonyl-leucyl-phenylalanine and insulin.
1.3.1.2. Differentiation of Human Promyelocytlc Cells 
along the Monocyte/Macrophage Pathway
Treatment of HL-60 cells with 12-0-tetradecenoylphorbol 
13-acetats (1PA) results In terminally differentiated 
cells with several characteristics of macrophage*
:P ivera et el., 1979). Addition of IP* to suspension 
cultures of HL-60 results In more than 80* of the cells 
adhering to the plastic substrate within 24 hr. Within 
the same time period immature azurophilic granulations 
typical of HL-60 promyelocytlc cells disappear, nuclear 
chromatin becomes more condensed, but the nucleolus i* 
retained. Attached cells stop dividing and DMA 
synthesis stops. The phenomenon is Irreversible and 
independent of the continuous presence of TPA There is 
no cb#ag* in the percentage of cells bearing surface PC 
receptors for IgG. Cellular levels of FADase, acid 
phosphatase and non-specific esterase are markedly 
increased after TPA treatment, thee* sumymas being 
characteristic of macrophages. More lyaomyme is found 
in the medium of TPA-treated cells than in the sidlum 
of untreated ceils which Is also characteristic of the 
macrophage phenotype sovera et aL. 1*7#).
1.3.1.3. Differentiation of Human Promvelocvtlc Cells 
along the Granulocyte Pathway
Treatment of HL-60 cells with dimethyl aulfoxide (DM80) 
results in terminally differentiated cells with several 
characteristics of mature granulocytes (Collins et al..
1978). The addition of DMSO to cultures resulted in the
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following- morphologic?. 1 changes: smaller size, 
decreased nuclerc/cytoplasmic ratio, less prominent 
cytoplasrr.lv granules, rrarked reduction or complete 
dissapearance of nucleoli and marked indentation, 
convolution and segmentation of the nuclei. Functio al 
changes include increased phagocytic ability.
Proliferation of HL-60 cells ceases after addition of 
DMSO and is irreversable.
1.4.0. VIRUS INTERACTIONS WITH MONOCYTES / MACROPBAGM
Macrophage# are susceptible to inf tion by a nttB1’. 
viruses and their function may b .'red a
despite their role as phagocytic evert u
preferentially replicate in macr r act5,
dehydrogenase virus (LDH) of mice oi ly . as in 
macrophages (Porter et a_l., 1969) l DH i; Of
a virus which appears to replivacc <n c# , i te 
infected host without causing any ' r it o^v.agv The 
virus impairs the clearance from * , 'i 1 t the
endogenous enzyme, lactic dehyd 11 vi u  - to*##
macrophages. Antigen presentation 1 •. 1 so affect id 
(Isakov ejt al., 1982) in infected cel’.ti, >ut all other 
functions appear lo be normal.
Macrophage resistance to virus infection may be of i 
types: extrinsic or intrinsic resistance (Stablest |t 
al., 1982). Extrinsic resistance of macrophages is
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defined as their ability to Inactivate extracellular 
viruj or reduce production in other surrounding cells 
that ire normally permissive, intrinsic resistance is 
defined as the permissive'-ess/non-permiseiveness ot »he 
macrophage itself for growth of a virus. The 
interaction may oe completely no,-specific or may be 
modified immunoloyically in either direction. For 
intrinsic Interactions, there may be a multitude of 
possible outcomes. These include abortive, cytolytic, 
p f  "latent, latent infections and transformations.
Interferons produced by macrophages appear to play a 
complex role in intrinsic resistance. Interferon, 
induced by a high multiplicity of infection with herpes 
simplex virus (HSV) was correlated with inhibition of 
productive virus replication in human monocytes in 
vitro (Linnavuori end Hovi, 1983).
Increasing evidence suggests that monocytes and 
macrophages also play a major role in the propagation 
and pathogenesis of HIV Infection. Monocytes can be 
infected in vitro with HIV and virus ca.i be isolated 
from blood and various organs of the HIV-infected 
individual (Nicholton et al„ 1986). In the brain 
monocvtes/macrophages are the major cell type infe »ed 
with HIV (Koenig et al., 1966). K number of monocyte
I
functional abnormalities have been reported in 
monocytes infected with HIV in vitro. These include 
defective chemotaxis and killing of microorganisms. 
Although these abnormalities may be solely due to 
direct infection of monocytes by HIV, it seems 
unlikely, as the frequency of infection of circulating 
blood monocytes is low. The deficiency of inductive 
signals from T4 cells is likely to contribute to 
functional defects in monocytes (Fauci, 1983). The most 
important implication of HIV- infected monocytes is the 
possibility that they serve as the major resevoir for 
HIV infection in the body, in view of the extended time 
frame (more than 5 yrs) from initial infection with HIV 
to clinically detectable disease manifestation.
Monocytes are relatively refractory to the cytopathic 
effects of HIV. The virus can therefore survive in 
these cells and be transported to various organs in the 
body such as the lungs and brain. Cells may survive 
that are either latently infected (integrated provirus 
without virus expression) or chronically infected 
(low-level virus expression). Activation signals are 
required for the establishment of a productive 
infection in v ro (Folks et al., 1986). In view of 
this, it is likely that various activation signals in 
vivc contribute to conversion from latent or chronic 
infection to productive infection, such as antigenic 
stimulation. Physiologic cellular inductive signals 
that might be encountered as part of the normal immune
X
response might also play a role. Folks et al.. (1987) 
showed that cytokine-containing supernatants from 
PHA-stimulated human mononuclear cells as well as 
granulocyte/macrophage-colony stimulating factor 
(GM-CSF) were capable of induci-.j virus expression in a 
latently infected, cloned, promonocyte cell line (0 1) 
which did not constitutively express virus. In 
addition, HIV infection of the 01 clone resulted i i 
upregulation of IL-18 expression, an indication that 
HIV infection may have important influences on the 
expression of certain cellular genes,
1.4.1. Effects of Activation and Differentiation 
Signals on Virus Interaction with Monocytes / 
Macrophages
Numerous studies have indicated that macrophage 
resistance to v ’-is infection (intrinsic resistance) 
changes with the state of differentiation of the 
macrophage. It is well estaolished that macrophages 
that differ in the state of activation, anatomical 
location or i_n vitro treatment show differences in 
resistance to infection by the same virus (Mjrahan et 
al., 1985). Infection of human macrophages ij% vitro 
with HSV-1 varies with the differentiation stcte of the 
macrophage (Daniels ejt al., lq78).
i
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response might also play a role. Folk? et al. (1987) 
showed that cytokine-containing supernatants from 
PHA-stimulated human mononuclear cells as well as 
granulocyte/macrophage-colony stimulating factor 
(GM-CSF) were capable of inducing virus expression In a 
latently infected, cloned, promonocyte cell line (Ul) 
which did not constitutively express virus. In 
addition, HIV infection of the Ul rlone resulted in 
upregulation of IL-18 expression, an indication that 
HIV infection may have important influences cn the 
expression of certain cellular genes.
1.4.1. Effects of Activation and Differentiation 
Signals c,» Virus Inter action with Monocytes / 
Macrophages
Numerous studies have indicated that macrophage 
reaiatance t- "irua Infection (intrineic resistance)
changes with the state of differentiation of the 
macrophage. It la well established that macrophages 
that differ in the state ot activation, anatomical, 
location or in vitro treatment show differences in 
resistance to infection by the same virus (Morahan et 
al., 1985). Infection of human macrophages in vitro 
with HSV-1 varies with the differentiation state of the 
macrophage (Daniels et al., 1978).
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response might also play a role. Folks et al. (1987) 
showed that cytokine-containing supernatants from 
PHA-stimulated human mononuclear cells as well as 
granulocyte/macrophage-colony stimulating factor 
(GM-CSF) were capable of induci,,j virus expression in a 
latently infected, cloned, promonocyte cell line (01) 
which did not constitutively express virus. In 
addition, HIV infection of the 01 clone resulted i t 
upregulation of IL-lB expression, an indication that 
HIV infection may have important influences on the 
expression of certain cellular genes.
1.4.1. Effects of Activation and Differentiation 
Signals on Virus Interaction with Konocytes / 
Macrophages
Numerous studies have indicated that macrophage 
resistance to virus infection (intrinsic resistance) 
changes with the state of differentiation of the 
macrophage. It is well established that macrophages 
that differ in the state of activation, anatomical 
location or hi vitro treatment show differences in 
resistance to infection by the same virus (Mjrahan et 
al., 1985). infection of human macrophages in vitro 
with HSV-1 varies with the differentiation state of the 
macrophage (Daniels et al., lt|78).
response might also play a role. Polks et ml. (1987) 
showed that cytokine-containing supernatants from 
PHA-stimulated human mononuclear cells as well as 
granulocyte/macrophage-colony simulating factor 
(GN-CSF! were capable of inducing virus expression in 
latently infected, cloned, promonocyte cell line (0 1) 
which did not constitutively express virus. In 
addition, HIV infection of the 01 clone resulted in 
upregulation of It-16 expression, an indication that 
HIV infection may have important influences cn the 
expression of certain cellular genes.
1.4.1. Effects of Activation and Differentiation
Signals c.i Virus Interaction with Honocvtes I 
Macrophages
Numerous studies have indicated that macrophage 
resistance t< "Irus infection (intrinsic resistance) 
changes with the state of differentiation of the 
macrophage. It is well established that macrophage* 
that differ in the state of activation, anatomical 
location or in vitro treatment show differences in 
resistance to infection by the same virus (Morahan et 
al., 1985). infection of human macrophages In vitro 
with HSV-1 varies with the differentiation state of the 
macrophage (Daniels et al., 1978).
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Studies of visna virus infection of sheep have 
suggested a crucial role for macrophage differentiation 
in the persistent nature of this disease (Gendelman et 
al., 1986). immature macrophages in the bone marrow 
show a restricted, no'*cytolytic pattern of visna virus 
infection. These cells give rise tv infected monocytes, 
which upon infiltrating an inflammatory site undergo 
differentiation to an inflammatory macrophage that 
triggers a productive, lytic infectior thereby serving 
to disseminate the virus.
HIV may also rely on persistent, noncytolytically 
infected macrophages to disseminate virus to tissue 
sites of inflammation such as the brain and lung 
(Streicher and Joynt, 1986). Recent reports have shown 
that treatment of the monocyte-like cell line, 0937, 
with agen'c that induce differentiation increased 
resistance to HIV {Hammer et al., 1986; Clapham et al.,
1987).1 f n - and GM-CSF increased resistance only when 
in culture both before and during the infection (Hammer 
et al., 1986). PM A (13-phorbol- -2-myrist*.te acetate) 
treatment has been reported to decrease HIV replication 
in U937 cells by decreasing the surface expression of 
the HIV receptor, the CD4 molecule.
Murine CMV can be activated to produce infection in 
teratocaccinoma lines only after differentiation is 
chemically induced by dimethylacetamide (Dutko and
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Oldsfeone, 1981). Gonczol et al. (1984) found that only 
human embryonal carcinoma cells induced to 
differentiate with retinoic acid expressed CMV antigens 
and produced infectious virus. Phorbol esters have 
repeatedly been shown to activate EBV replication in 
lymphoblastoid cell lines that ate low level producers 
of infectious EBV particles (Yamamoto and Zur Hausen, 
1979).
Tenney and Morahan (1987) have characterised the effect 
of differentiation on the resistance of the mononuclear 
phagocyte to HSV-1 using U937 cells. Replication of 
HSV-1 was compared in undifferentiated U937 cells and 
in cells induced to undergo differentiation by PM A 
treatment. Undifferentiated cells were highly resistunt 
to infection while PMA-differentiated U937 cells 
acquired full susceptibility to HSV-l-induced 
cytopathic effects. U937 cells were also induced to 
differentiate by treatment with retinoic acid, DMSO and 
lyaphokine. The change in permissiveness, however, was 
uniquely associated with PM A treatment.
Undifferentiated U937 cells adsorbed as much virus as 
PM A-differentiated cells, but immunof louresence assays 
as well as DMA hybridization analysis demonstrated an 
early block in replication in undifferentiated cells, 
be£o:*e syntnesis of viral protein and DMA. it was also 
established that PM A must be added before infection, 
suggesting that replication is enhanced as a result of
the differentiated phenotype.
Weinshenker et al. (1988) have made a similar study of 
BCMV infection of human monocyte cell lines. They 
studied the susceptibility of a number of different 
cell lines to infection by HCKV in vitro. These were 
HOT 102, THP-1, MOLT-4 and HL-60. THP-1, a monocytic 
cell line, could be infected by HCMV with a full cycle 
of replication after induction with TP A which results 
in differentiation of the cell line into cells with 
characteris cs of mature macrophages. HL-60, a 
promyelocytic cell line, was not susceptible to CWV 
infection after induction with TPA, suggesting that 
cell lineage was important. They were not, however, 
able to establish whether the enhanced susceptibility 
of THP-1 to CMV was due to an increase in viral 
attachment and penetration U.e an increase in 
receptors) or to enhanced transcription of the 
intracellular viral genome. Failure to induce 
expression of the virus by treatment with TPA after 
infection suggested that the enhancement was due to an 
increase in viral receptors.
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1 4.2. Interaction of HCMV with Hor.ocvtes
Virus-monocyte interactions were evaluated in patients 
with mononucleosis due to HCMV {Carney and Hirsch 
1991), The study showed that the suppressor cell during 
acute HCMV mononucleosis had the characteristics of 
cells of the monocyte-macrophage series and was 
infected with HCMV. In addition, monocytes from 
uninfected control donors were infected in vitro with 
HCMV and evaluated for rhe induction of suppressor 
activity. HCMV-infected monocytes were significantly 
more suppressive for autologous lymphocyte responses to 
con A than were ininfected monocytes.
Binhorn and Ost (1984) showed that clinical isolates of 
HCMV, passaged one to ten times in vitro, regularly 
induced HCMV early antigens in human leukocytes. The 
population of leukocytes that were most positive for 
HCMV early antigens ( BAs) were monocytes. No evidence 
of viral production was found. In contrast, EA-positive 
leukocytes were only rarely found after exposure to the 
HCMV laboratory adapted strain, AD169„ These findings 
were corroborated by Rice et al. (1984) who 
demonstrated that HCMV could infect T and B 
lymphocytes, natural killer cells and monocytes. Virus 
expression was limited to the synthesis of 
immediate-early {IE) HCMV polypeptides and this 
abortive infection was also
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most convincingly shown by strains of HCMV recently 
Isolated from infected patients. In this study, 
monocytes were also found to comprise the cell 
population with the greatest proportion of cells 
expressing the IP gene product. In addition, infection 
of peripheral blood mononuclear cells with low passage 
isolates completely abrogated their response to PH A,
Kapasl and Rice (1936) have confirmed that the 
immunosuppressive effect of HCMV depends on the 
presence of monocytes in the cultures. They found that 
monocyte viability was unaltered by HCMV infection, but 
that phagocytic activity and respiratory burs1 were 
markedly suppressed. Kinetic studies revealed -hat the 
suppressive effect required at least 24hr to develop 
after infection.
1.5.0, INTERLEUKIN 1
1.5.1. Cell Sources of Interleukin 1
Interleukin 1-like factors are still identified by 
their ability to activate thymocytes. IL-1 is 
distinguished from IL-2, the only otter cytokine known 
to have thymocyte activating activity, by its inability 
to support the growth of 11,-2-dependent lymphocyte cell 
lines. Many cell types have been documented to produce 
IL-l-like activities (Dinarello, 1984; Oppenheim et
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al., 1986), although the biochemical properties of the 
IL-1 activities produced by these diverse cell types 
have only baen partly defined. Many non-monocytii cells 
produce IL-l-like activity with the same molecular 
weight and major pi's as monocyte derived IL-1. IL-1 
mediates several diverse biological activities 
including induction of fever, stimulation of secretion 
of acute phase proteins from hepatocytes, PGEj from 
fibroblasts and synovial cells and a maturational 
influence on T and B lymphocytes (Appendix A).
1.5.2. Production and Release of IL-1
Most norir.al cell types and a number of coll lines 
produce IL-1 only in response to a variety of 
stimulants, although some transformed B and T cell 
lines spontaneously produce soluble IL-l-like factors. 
Reports of constitutive production of IL-1 by normal 
cells can probably be attributed to a continuation in 
vitro of a response to ptior stimulation in vivo or as 
a result of a contaminating stimulant such as the 
ubiquitous endotcin (LPS). Stimulants that induce IL-1 
synthesis by monocytes act on the plasma membrane. For 
monucytes and macrophage cell lines, stimulants include 
LPS, PM A, CSF and I!" N y , with LFS being the most potent 
soluble inducer in vitro. Following LPS stimulation, 
low levels of IL-1 appear very rapidly (intracellular 
IL-1 activity appears within 30 min and extracellular
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IL-1 within 60 min). High levels of intracellul 
extracellular IL-1 are reached 3h after stimu^ .*on and 
this LPS-induced increase is both actinomycin D and 
cycloheximide sensitive, thereby excluding a major 
contribution to IL-1 production by either preformed 
mRNA or protein (Oppenheim sr. al., 1986). Further 
studies by Fenton et al. (1987) have shown that 
cycloheximide inhibition of de novo protein synthesis 
results in superinduced levels of IL-ldmRNA (400-600 
fold over background) with accumulation rates and decay 
kinetics being identical. IL-16 is thus a transiently 
expressed, tightly regulated gene which implies a novel 
role for proIL-16in monocyte differentiation 
particularly when considering that most of the IL-18 
synthesized remains inside uhe cell (Matsushima et al., 
1986). A puzzling feature of the IL-1 protein is its 
lack of a signal sequence which 's t sually 
characteristic of secreted proteins that are 
transported from an intracellular to an extracellular 
environment. This feature raises questions about 
whether IL-1 is tru1y a secretory protein ard by what 
mechanism it is released from cells (Oppenheim et al., 
1986)
Several investigators have shown that essentially all 
IL-1 is the product of two genes, designated as IL-l<x 
and IL-1S that each encode distinct polypeptide 
products (Auron et al., 1984; March et al., 1985). The 
products are clearly defined on the basis of distinct
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isoelectric points (namely pi 5 for IL-1 a and pi 7 for 
XL-l $ ), but have indistinguishable biological 
profiles. Common structural genes essential to function 
are found in both IL-la and IL-16 , which accounts for
their sim.lar biological activities.
Comparison of the gene sequences has revealed extensive 
similarity of genomic organization. Both the IL-la and 
the IL-1 Bgenes are split into seven exons, but the 
primary transcription products (7 kb for the beta gene 
and 10.2 kb for the alpha gene) are consistent with the 
relative mRNA sizes (1.5 kb for bet t and 2.2 kb for 
alpha). Despite the poor overall amino acid homology 
(25%), there is a' gh conservation of organization for 
both exon size and position of splice junctions. 
Furthermore, the evolutionary constraints on this 
genomic pattern of organization have been maintained 
despite a sequence divergence of 45% (March et al.,
1985). The paradox of the existence and functioning of 
two genes with indistinguishable biological activities 
is further complicated by differential expression of 
these two genes. Human monocytes transcribe the IL-lii 
gene 10-50 times more efficiently than the IL-la 
sequence (March et al., 1985) and consequently produce 
about 10 times more pi 7 than pi 5 IL-1. This may be 
due to a more efficient set of typical eukaryotic 
promoter elements found in association with the IL-lB 
gene. The IL-1 ^precursor may be active without
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processing {van Damme et al., 1985) whereas the IL-Ic* 
precursor may require cleavage. Considerable IL-1 
activity can be extracted from cells with detergent and 
much of this cell- associated IL-1 activity is located 
in the cytosolic fraction of the cell. However, IL-1 
activity that is exposed on the macrophage plasma 
membrane has been detected by Kurt-jones et al. (1985).
Gel filtration or high pressuie liquid chromatography 
reveals that a low level of the cell-associated IL-1B 
activity is associated with a 30-kDa precursor moiety, 
whereas most of the activity extracted with detergent 
from both cytosol and membrane exhibits a mw of 23kDa. 
In view of the absence of a nucleotide sequence in the 
cDNA for IL-1* or B that codes for such a signal 
peptide, it has been postulated that the IL-1 precursor 
undergoes sequential enzymatic cleavage into 
progressively smaller peptides from the biologically 
inactive 31 kDa precursor form to an intermediate 23 
kDa intracellular and membrane form and subsequently to 
a 17 kDa extracellular peptide. Conlon et al. (1987) 
have performed studies on the localisation of the » 
and 8 forms of IL-1 in human mononuclear cells. They 
have demonstrated by two distinct criteria, flow 
cytometry and inhibition of biological activity of cell 
bound IL-1, that the « form is associated with the cell 
membrane, whereas the 8 form was not detected. If IL-18 
was present on the surface, it might be there in a
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biologically inactive form. Indeed, Mosley et al.
(1981) shown that only the processed 17 kDa form
of IL-10 is active. Their conclusions were that IL-Ia 
is preferentially associated with surfaces of cells, 
particularly those involved in antigen presentation, 
while the 1L-16 f o m  remains predominantly inside the 
cytoplasm and is only secreted upon stimulation.
1.3.3, Receptors for IL-1
The availability of purified recombinant IL-1 has made 
it possible to label IL-1 with ^25^ tQ 36tec;t 
receptors on cell surfaces (Dower et al., 1985). In 
this study, it was found that a wide variety of cell 
types have a low number of binding sites. Fibroblasts 
had the highest number of sites (1500-5000 sites/cell). 
The murine T lymphoma LBRM-33-1A5 r.,-1 dependent cell 
line bound 500 - IL-1 molecules / cell at
saturation nd of 12 polypeptide hormones, only IL-1 
competed with labelled IL-1 in a dose dependent manner. 
A membrane polypeptide of mw 79 500 was found to be 
croselinked to IL-1. Dower et al_. (1985) also observed 
that unlabelled IL-1& competed equally with IL-1B for 
binding sites, suggesting that receptors for the two 
molecules may be identical. A cDNA clone encoding a 
molecule of 576 amino acids corresponding to the IL-1 
receptor has been isolated (Sims et al., 1988). This 
transmembrane molecule appears to be a member of the
gene family. Mutations of a unique histidine residue 
(position 30) in IL-18 resulted in a 100 fold reduction 
in receptor-binding affinity (MacDonald et al., 1986 ).
Paradoxically, only 50 IL-1 binding sites / cell have 
been observed for peripheral T lymphocytes (Dower et 
al., 1985) - the reason for such a low detection is 
unknown. Little Is known concerning iochemical events 
following interaction of IL-1 with its receptor. The 
calcium ionophore, A23187, has been shown to 
synergistically enhance the effects of IL-1 in the 
thymocyte activation assay (Matsushima and Oppenheim, 
1985). This suggests that IL-1 depends on calcium 
channel formation for its effects, but attempts to 
ascertain whether IL-1 rapidly influences the 
Intracellular activity of protein kinase C have been 
unsuccesful.
1.5.4. Genomic Structure of IL-1
1.5.4.1, Homology Regions within IL-1 Molecules
Since both IL-le and IL-lfl cDNAs have been shown to 
code for biologically active IL-1 , regions of homology 
between the two DMA sequences could identify the 
important regulatory functions of these proteins. The 
regions of strongest homology between the
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human 1L-1 ct and human IL-IB genes respectively, are 
known as the and R2 regions (Figure 3) ,
March et al. (1985) have shown that biological activity 
is conveyed by 159 and 153 amino acids from the C - 
terminal end oE the Ir.-1 a and IL-1B molecules 
respectively. They suggest that the primary difference 
between the IL-la and IL-18 species is that the primary 
translation product of the XL-10 is biologically 
active, while that of IL-la is not, as determined in a 
reticulocyte lysate system.
1.5.4.2. Regulation of IL-1 Gene Expression
Oppenheim et al. (1986) have analysed the rate of IL-1 
mRNA accumulation in peripheral blood monocyte.* and 
also observed differential expression of the IL-kx and 
IL-16 genes. Dot blot analysis revealed that the levels 
of TL-18 mRN A began rising 1 hour after stimulation of 
cells with LPS, reaching a maximum 6 hours after 
treatment and was 40 fold greater than the level 
measured in unstimulated cells. Spontaneous expression 
of low levels of both IL-la and IL-2B mRNA by the 
monocyte population was also observed. Following LPS 
stimulation, the amount of IL-la and P. mRNA produced by 
human monocytes determined
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Figure 3
Schematic representation of IL~lfi putative regulatoryregions (after Clark ct al 1988) and sequences tested in cotransfectionexperiments together with H C M V  IE gene region constructs
)S X 32  X10
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the relative amount of IL-1" and 6 protein produced by 
the cells and 10 fold greater concentrations of both 
the IL-16 mRNA and protein were measured compared with 
the levels of IL-l™ .
1,5.4,3. Role of els and trans acting elements 
Involved in expression of the ptolL-if gene.
Fenton et al. (1987) showed that the proIL-16 gene was 
differentially expressed in human monocytic cells 
following induction with LPS or PM A and that the 
kinetics of IL-16 expression is stimulant specific. LPS 
stimulation results in rapidly and transiently 
expressed IL-1S message whereas PMA leads to a much 
slower appearance and decay of IL-18 mRNA,suggesting 
separate membrane receptor/transduction systems for LPS 
and PMA. These data also suggested a model for 
regulation involving a transcriptional activator during 
the induction of the IL-1 8 gene followed by the action 
of a repressor to partially down-regulate 
transcription. Clark et al. (1988) therefore 
investigated whether cis and trans-acting elements may 
be involved in the regulation of the IL-38 gene.
Two approaches were used to analyze DMA sequences 
upstream of the transcriptional initiation site of the 
proIL-le gene. The first used chimeric plasmids 
containing prolL-18 DMA sequences fused to the
ybacterial CAT gene. The insertion of the proZL-lB 
promoter in front of the promoter-less CAT gene allows 
for promoter testing by the expression of C&T in a 
transfected host cell. Using this technique, they have 
identified cis-acting sequences of the prolL-18 gene 
necessary for expression of the gene. In order to 
define the cis-acting sequences necessary for 
expression, they tested constructs containing 
successively smaller fragments of the proIL-18 upstream 
sequence generated by progressive cleavage at specific 
endonuclease sites. Clones designated PT, &T, DT, NT 
and HT contained 1097, 513, 314, 235 and 132 bp of 
upstream IL-16 sequence respectively. Secondly 
electrophoretic gel mobility shift assays were used to 
identify sequences to which trans-acting factors could 
bind. This method provided additional information on 
the regions identified by the CAT functional analysis 
by determining if nuclear factors bound to cis-acting 
sequences.
Four different human cell lines, THP-1, U937, Colo/16 
and HeLa were transfected with the various IL-1B - CAT 
plasmids. The data showed that the proTL-16 upstream 
sequences were only able to direct CAT expression in 
monocytic THP-1 and U937 cells and net in non-monocytic 
HeLa and Colo/16 cells. IL-16 - CAT constructs 
containing the SV40 enhancer could direct CAT 
expression in all cell types tested but, without the 
enhancer, only monocytic cell lines could express CAT.
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In THP-1 cells, the DMA fragment containing the 
homology region was required to direct CAT expression. 
This expression was increased by additional sequences 
extending into and beyond the region. Clones AT 
and PT with 513 and 1097 bp of upstream 1L-18 sequence 
and containing the R, fragment, directed CAT 
expression with nearly equal efficiency with or without 
the SV40 enhancer. Clone DT with 314 bp did not, 
suggesting that DNA sequences between -513 and -314 
possessed enhancer-like activity.
The two upstream regions which were used as 
radiolabelled probes in the band shift assays contained 
the R, and R% regions respectively. These fragments 
were incubated with nucl ir extracts from unstimulated 
or LPS-stimulated (for 1 or 5hr ) THP-1 cells. Specific 
regions of the proIL-18 upstream sequence that bound 
nuclear factors were ic entitled. A factor present 
maximally in 5hr extracts and specific for THP-1 cells, 
bound to the fragment containing the R^ regicn with a 
kinetic binding profile reflecting that previously 
proposed for a transcriptional repressor that 
down-regulated IL-1B transcription.
1.5.5. Effect of IL-1 on T Cells
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h recent model attempting to explain the function of 
IL-l in T cell activation is that of Wlzel (1987), In 
the presence of a specific antigen or T cell mitogen, T 
cells and accessory cells are mutually stimulatory. The 
accessory cell is induced to begin IL-l synthesis and 
secretion. In return, T cells initiate IL-2 and IL-2 
receptor synthesis and expression. In addition T cells 
are stimulated to produce IL-l receptors and thus 
become fully responsive to IL- l. IL-l responsiveness 
confers upon the T cell a heightened ability to produce 
IL-2 and IL-2 receptors in response to processed 
antigen / class II MHC antigen or mitogen. Interaction 
between IL-2 and its receptor then results in T cell 
proliferation. Activated T cells may also produce a 
lymphokine that augments the ability of accessory cells 
to produce IL-l thus providing for a secondary 
amplification loop in the interactions of T cells and 
accessory cells.
IL-2 is the sole requirement for stimulation of the 
enti.e series of events known as G^ progression in 
cells (Stern and Smith, 1986). IL-2 receptor density 
and the absolute number of receptor interactions 
determines the time required to transit the phase.
At the level of the single cell, progression to ON A 
replication is determined precioely by a finite number 
of IL-2 receptor interactions. The actual molecular 
mechanism underlying competence, or Gg to C,
transition. Is the expression ot IL-2 receptors (Seith,
1988). In contrast, IL-2 promotes a gradual and 
sustained increase in cell size, known as the 
lymphocyte blastic transformation, and prepares the 
cell metabolism for DNA replication.
In addition to its effects on IL-2 production and 
action, IL-1 also induces other T cell effects 
including changes in membrane viscosity (Puri et 
al.,1960) and increased chemotaxl* (hlossec et 
al.,1984). The production .if several other T cell 
lymphokines in addition to IL-2, increases following 
IL-1 exposure. These include IPS- y and CSP (K is-hara et
aw***).
1.8.0. BPf8CTS OP VIROS INFECTION ON INTERLEUKIN 1 
AND 2 PRODUCTION
Rodgers et a^. (1985) showed that infection of human 
monocytes with the AD169 strain of HCMV abrogates their 
production of functional IL-1 bioactivity. This was 
associated with the release from infected monocytes of 
an inhibitor of IL-1 activity, which was also released 
after HCMV infection of rhe V937 macrophage-like cell 
line. It appeared that the inhibitor decreased the 
proliferation of the IL-1 responsive cells in the IL-1 
assay ( ymocytes). The action of HCMV strain AD169 was 
virus specific and required Infectious virus but
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occurred without virus replication or detectable 
expression of viral proteins, Fractionation studies did 
not reveal whether both inhibitor and IL-1 are present 
in supernatants of HCMV-infected monocytes at the same
time.
In a different study by Smith at al. (1"5) it was also 
shown that HCMV infection depressed monocyte production 
of functional IL-1 bioactivity. In both LPS-stimulated 
and unscimulated monocytes, IL-1 production by 
HCMV-infected monocytes was significantly depressed as 
determined by the thymocyte proliferation assay.
However, in this system, CMV did not induce monocytes 
to release an inhibitor of thymocyte rroliferation. The 
reduced proliferation was also not due to an increase 
in prostaglandin B (PGB) production.
Kapasi and Rice (1988) also investigated the role of 
IL-1 and IL-2 in HCMV-mediated immunosuppression in 
vitro and found that HCMV infection of monocytes, 
lymphocytes rr PBMC resulted in reduction of IL-1 and 
IL-2 production in the cultures. Addition of exogenous 
IL-1 or IL -2 did not restore these responses. However, 
if reduced production of IL-1 or production of an IL-1 
inhibitor had been the only flaw, PBMC should still 
have responded tc IL-2 which they did not. There was 
also no evidence of an IL-2 inhibitor, suggesting that
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CMV causes a metabolic derangement in lymphocytes and 
monocytes and Impairs their ability both to produce and 
respond to physiological mediators of the immune 
response.
Roberts et al. (1986) examined IL-1 and IL-1 inhibitor 
production by human monocytes exposed to influenza 
virus or respiratory syncytial virus (RSV) and showed 
that both influenza virus and RSV induce concomitant 
production of IL-1 and IL-1 inhibitors by peripheral 
blood monocytes. The net IL-1 activity produced after 
exposure to influenza virus resulted in enhanced 
th&mocyte proliferation to PH A. In contrast, lymphocyte 
proliferative responses to mitogens and antigens were 
significantly depressed in the presence of Influenza- 
infected monocytes. This suggests that this phenomenon 
was not due to inability of the infected monocytes to 
produce IL-1, but rather the effect of concomitantly 
produced inhibitors to IL-1. The net IL-1 activity 
produced by RSV-infected monocytes resulted in marked 
inhibition of thymocyte proliferation, either in 
response to any IL-1 activity that was produced at the 
same time, or in response to exogenous IL-1 added to 
the cultures.
Berman et al. (1987) performed studies using peripheral 
blood mononuclear cells from AIDS patients. In this 
study, however, in addition to finding marked increases
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in the amounts of 50 000-100 000 and 6 000-9 000 
molecular weight factors which inhibited 11,-1 activity, 
results showed that PBKCs from patients with AIDS 
produced increased amounts of the 30 000-40 000 mw fotm 
of IL-1 compared with those of controls. The action of 
the 6 000-9 000 mw inhibitor of functional IL-1 
activity appeared to be directed specifically against 
the maturational effect of IL-1 on immature T 
lymphocytes (thymocytes) - the same phenomenon reported 
by Rodgers et_ al. (1985) for CMV-infected monocytes.
The inhibitor of functional IL-1 activity produced by 
PBMCs from AIDS patients did not inhibit proliferative 
responses to mitogens by peripheral blood T lymphocytes 
or IL-2 action or synthesis. The increased activity of 
an IL-1 form with higher mw in AIDS suggests either a 
decrease in 11-1 processing to the 17 000 mw form 
(Auron et a l . ,1984) or preferential synthesis off a 
certain type of IL-1# since IL-1 appears to represent a 
family of related peptides (Billian et al.,1985).
Monocytes / macrophages also comprise cells oK 
different stages of differentiation or activation which 
ace likely to exhibit different properties xn IL-1 
production (Khansari et al.,1985). Such subsets of 
cells could be altered in AIDS. A change in monocyte 
differentiation or activation could be a result of the 
continuous activation of monocytes by the various 
opportunistic infections that accompany AIDS, or 
directly through infection of monocytes / macrophages 
by HIV.
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In a study by Gupta et al. (1987), 1L-1 aitlvlty In the 
supernatants o( cultured peripheral blood eoeocytes 
from patients with aids was examined. Spontaneous IL-1 
production was significantly increased in patients with 
AIDS, whereas IL-1 production by LPE stimulated 
monocytes was significantly decreased, they suggest 
that in the early stage of the disease, adherent cells 
are activated in vivo. However, with progression of 
immune deficiency, -dherent cells are fractionally 
deficient. They did not assay for the simultaneous 
production of an IL-1 inhibitor by the 11 5-uriaula-ed 
monocytes.
Under normal conditions, the release of IL- ’ end IL-1 
inhibitors ays a role In tissue homeocta-la (Larrick, 
1989). Several molecules with inhibitory activity
(as tested in a limited number of assays) have been 
identified and partially char&cteriaed. factors with 
distinct molecular weights of 8, 20 - 25 and 95 kDa 
have been Identified. Molecules that limit 
transcription of IL-1, bind directly to the IL-1 gene, 
bind to its receptor or act at other site.! o limit the 
activity of the receptor nave been lesc.ibe U The 
altered production of IL-1 and/or IL-1 rnhiiltote in 
AIDS and other viral diseases may play a major role in 
the immune disfunction associated with these diseases 
(Larrick, 1989). The isolation and cDNA cloning of the
mRNAs giving rise co these molecules will permit their 
evaluation as modulators of immune function.
Folks et al.(1987) established a model system for 
cytokine-induced up-regulation of HIV-1 expression in 
chronically infected promonocyte clones. The parent 
promonocyte cell line 0937 was chronically infected 
with HIV-1 and from this line a clone. Ul, was derived. 
01 showed minimal constitutive expression of HIV-1, but 
virus expression was markedly up-regulated by & 
PHA-induced supernatant containing multiple cytokines 
and by recombinant GM-CSP alone. Recombinant IL-1, 
IL-2, interferon—f and tumour necrosis factor (INF), 
did not up-regulate virus expression. Concomitant with 
the cytokine-induced up-tegulatior, of HIV-1, expression 
of membrane bound IL-18 was selectively induced in Ul 
in the absence of induction of other surface membrane 
proteins. This cytokine up-regulation of IL-18 was not 
seen in the uninfected parent U937 cell line. These 
studies have implications for the understanding of the 
mechanism of progression from a latent or low-level 
HIV-1 infection to a productive infection with 
resulting immunosuppression. In addition, this model 
can be used to delineate the potential mechanisms 
whereby HIV-1 infection regulates cellular gene 
expression. Additional studies wero performed to 
determine whether HIV induction occurred via activation 
of the HIV promoter. Constructs made from the HIV long
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terminal repeat (LTR) and the CAT gene were transfected 
into 0937 calls. Transfected cells were exposed to 
cytokines and showed increased levels of CAT activity, 
suggesting that the site of cytokine-induced activation 
resided in the LTR Rabson and B.Duh et al„ 
unpublished observations. In Rosenberg and Rauci,
1989). To further identify specific sites on the HIV 
LTR that were involved in virus induction, gel 
retardation experiments were performed using labelled 
oligonucleotides in the presence of nuclear extracts 
from stimulated and unstimulated cells. Nuclear 
extracts from p h a  supernatant-stimulated cells retarded 
mobility of oligonucleotides from the HIV LTR region.
The retardation could be nhibited by probes to 
binding sites within the transcription initiation 
region. The induction of virus expression from latently 
or chronically HIV-Infected cell lines therefore occura 
as c result of the interaction of specific DNA-binding 
t.oteinn with the HIV LTR.
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1.7.0. A I K #  O F  T B I S  S T O P !
Monocytes play an Important part In boat defence 
against virus infection and in the case of HCMV may 
also be the reservoir tor latent disease. The highly 
variable state of stimulation and/or differentiation 
that cells of the mononuclear phagocyte series may 
exhibit and the influence that this may have on the 
outcome of virus infection at functional and molecular 
levels have been the aims of investigation in this 
study.
At a functional level, monocytes play an essential role 
in the initiation of immune responses through antigen 
presentation and production of IL-1" and other 
mediators. Impairment of these accessory cell functions 
could be a major factor contributing to the 
immunosuppression and pathology of HCMV infection.
At a molecular level, there has been considerable 
Interest in the IE gene products of HCMV since they 
possess transactivating properties and have been shown 
to transactivate transcription from viral and cellular 
promoters. Alteration in transcription of host cell 
genes might therefore also contribute to the pathology 
of infection at a molecular level.
The aims of this study therefore can be listed as 
follows:-
1. To evaluate the effect of HCMV infection on 
monocyte accessory cell functions, notably production 
of IL-1 bioactivity which is required for T lymphocyte 
responses to mitogens.
2. To compare effects of HCMV infection u,i production 
of IL-1 bioactivity in stimulated and unstimulated 
peripheral blood monocytes, in an attemp*. to evaluate 
an in vivo situation in which HCMV infection is 
frequently accompanied by superinfection with other 
organisms.
3. To evaluate effects of HCMV infection on expression 
of IL-10 steady state mRNA in peripheral blood 
monocytes.
4. To investigate the influence of various 
differentiation states on tho expression of mediator 
genes in HCMV-ir.fecced and uninfected monocytes. In 
order to investigate the effect of HCMV exposure in 
terms of an overall response to infection and 
inflammation, the expression of IL-16 and several other 
monocyte-associated genes were studied. This was done 
using a promyelocytic cell line which can be induced to 
differentiate along d t'ferent ccllulai lineages.
5. To determine whether the IE gene products of HCMV 
are capable of activating transcription of the IL-K 
promoter.
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2.0.0. MATERIALS AMO ti£THOi)S
2.1.0. Antibody Statua of Donors
Peripheral blood monocytes and autologous T lymphocytes 
were obtained fro* ten healthy adults, all of whom were 
seronegative for HCMV as u.terrolned by enzyme-linked 
immunosorbent assay (ELISA).
2.2.0. Isolation and Separation of Mononuclear Cells
Heparlnised (150/ml) human peripheral blood was diluted 
1!2 with endotoxin free phosphate buffered saline 
(PBS), and separated into mononuclear and 
polymorphonuclear cell fractions using lymphocyte 
separation medium (Plow Labs. Inc., C.A., USA). The
mononuclear cells were washed twice In endotoxin free
PBS and once with endotoxin free RPMI 1640 culture 
medium (Cellgro, Medlatech) containing penicillin 
(100U/-1), streptomycin (ICOug/ml) and L-glutamine 
(2b M). They were then resuspended in RPMI 1640 and 10% 
heat inactivated (56‘C for 30 min) AB serum (south 
African Blood Transfusion Service, Johannesburg, SA), 
free of antibodies to CMV. Monocytes were removed by 
adsorption onto the flat surfaces of 100mm tissue 
culture petti dishes (Falcon Plastics. Oxnard, C.A., 
OSA) at 37°C for 50 min. After incubation, the 
nonadherent cells were removed by washing with RPMI
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1640. This nonadhecent fraction is referred to as the 
lyFphocjt? population. Monocytes were recovered by 
incubating the adherent cells on the surfaces of tissue 
culture petti dishes with Veraene solution (Gibco Labs, 
Grand Island, N.Y., USA) for 20-25 min at 4°C with 
occasional gentle shaking. After removal, monocytes 
were washed three times with RPMI 1640 medium. The 
resulting cell population was >95% monocytes as 
determined by non-specific e*te:a#e staining, and i-.he 
viability was >95% as determined by trypan blue dye 
exclusion.
2.2.1. Non-specific Esterase Staining of Monocytes
Esterase staining of monocytes was performed using 
the a -napthyl acetate esterase staining kit (Sigma 
Diagnostics, St. Louis, MO., USA) according to 
manufacturers specifications.
2.2.2. Separation of T Lymphocytes
T lymphocytes were separated from other non-adherent 
cells by differential centrifugation of lymphocytes 
rosetteU with sheep red blood cells (SRBC! treated with 
2-amincethyl-isothiouronium bmmide (AST), using the 
method of Boylston and Anderson (1979) (appendix 1). 
AET-treated SRBC were prepared from packed SRBC washed 
three times in PBS using centrifugations of 1000 y
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for 10 mins each. Two and a half ml AET solution was 
added to 0,5 ml packed SRBC and incubated at 37®C for 
15 min with gentle agitation. The SRBC were then washed 
with PBS until there was no haemolysis and resupended 
to a 10% concentration in RPMI 1640 and 10% 
heat-inactivated fetal calf serum (PCS) (Hyclone,
Logan, UT, USA), preabsorbed with SRBC (appendix 1).
The final cell density of non-adherent cells was 
adjusted to 3-4 x 10^ cells in 2,5 ml RPMI 1640 and 
incubated at 37 t  with C,5 ml of AET-treated SRBC and 1 
ml of PCS preabsorbed with SRBC. The suspension was 
incubated for 15 min with gentle agitation and 
subsequently pelleted by centrifugation. After 
overnight incubation at 4 ■£ the pellet was resuspended 
by gentle agitation of the tube. The suspension was 
underlayed with a 10 ml cushion of lymphocyte 
separation medium (LSM) (Flow Labs.Inc,. C.A., USA) and 
centrifuged at 1000 g for 30 min. SRBC-rosetted cells 
(T lymphocytes? pellet through the LSM cushion, while 
iion-rosetted cells remain at the interface. T 
lymphocytes were recovered by lysis of SRBC using 
freshly prepared cold (4°C ) ammonium chloride lysing 
buffer (appendix 1), after which the cells were washed 
three times in RPMI 1640. Viability was assessed by 
trypan blue dye exclusion and was >95%.
2.3.0. Culture oi ML-3 Cells and Induction of Cell
Differentiation
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ML-3 cells were grown in endotoxin free RPMI 1640 
supplemented with 10% PCS (Hyclone, Logan, OT, USA) and 
were subcultured every four days by resuspending at 
2x10^ cells/ml in fresh media. For induction of cell 
differentiation, ML-3 cells were cultured in complete 
RPMI 1640 containing 10 ng/ml 13-phorbcl-12-myristate 
acetate (PMA) or 10 ng/ml dimethylsulphoxide (DMSO) for 
24 hr and then washed twice with RPMI 1640. Trypan blue 
dye exclusion showed that viability at the time of HCMV 
infection was >90% for control and PMA treated cells.
2.4.0. VIRUS STRAINS
2.4.1. CMV Strain AS169 and Towne Strain
Human embryonic lung fibroblasts (HEL) (Flow Labs.
Inc., C.A., USA) were grown as monolayers in 25 cm2 
plastic tissue culture flasks (Falcon Plastics, Oxnard, 
CA, USA) in Eagle's minimal essential medium (MEM) 
(Gibco Labs,. Grand island, NY, USA) supplemented with 
10% PCS (Flow Labs. Inc., C.A. USA). Once a confluent 
monolayer had been obtained, cells were trypsinised 
using 0,25% trypsin (w/v), and the cells seeded into 
two n -w flasks of the same size. Stock virus was 
obtaiied by infecting a 90% confluent HEL monolayer 
with virus at a low multiplicity of infection (0.1 
pfu/cell). After 90 min adsorption, the inoculum was
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removed and rep: wi':h Eagle's MEM supplemented with
6% (v/v) heat inactivated PCS. Culture supernatant 
containing virus was collected 7 days after inoculation 
and the quantity of virus determined by plaque assay 
(appendix 2). Virus was used for infection when the 
titer was 10' pfu/ml in BSi*.
2.4.2. Clinical Isolate Strain
A fresh isolate strain of human CMV, V3474 - 84, 
(obtained from the virology laboratory. Medical 
University of South Africa) was isolated from the urine 
of an adult with CMV mononucleosis and passaged three 
times in mycoplasma-free HBL. Infected fibroblasts 
showing characteristic CPE were harvested and virus 
containing medium from passage three was used for 
infection of cells. The titre of the fresh isolate was 
IxlO4 pfu/ml in HBL.
2.5.0. Stimulation of Monocytes and Production of 
IL-1 Containing Supernatants
Monocytes were stimulated with lipopolysaccharide (LPS) 
from E.coli (Difco, Detroit, Mich., USA) for the 
generation of IL-1 containing supernatants (Lachman et 
al. (1977). Monocytes were resuspended to a 
concentration of 2 xlO6 per nU in RPMI 1640 and 5% 
heat inactivated AS serum. Aliquots (2 ml), were plated 
into 60 mm tissue culture dishes (Costar), with
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or without lOug/ml LPS. Dishes were incubated for 20 
he at 37"c in a humidified atmosphere containing 5%
CO, in air. Supernatants were collected by 
centrifugation at 800g for 10 min and frozen at -2 j*C 
until used.
2.6.0. Virus Infection of Xonocvtes and ML-3 Celia
Virus was added tc cell pellets in polypropylene tubes 
at varying multiplicities of infection (MOD and 
Incubated for 2 hrs at 37"c with gentle agitation 
every 20 min. After inf' c1-lor , the cells were washed 
twice in RPMI 1640. Monocytes were resuspended to a 
concentration of 1x10* cells/ml in RPMI 1640 and 10* 
heat inactivated AB serum and ML-3 cells resuspended 
to '".ne same concentration in RPMI 1640 and 10% PCS. 
Stimulated and unstimulated monocytes and ML-3 cells 
were mock infected with growth medium from uninfected 
fibroblasts.
2.7.0. Assessment of T Lymphocyte Transformation
Autologous T lymphocytes were prepared by differential 
centrifugation of lymphocytes rosetted with sheep red 
blood cells treated with AET, as described above.
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T lymphocytes wet< warhed and resuapended to a 
concentration of Ix .0® cells/ml In RPMI lf40 and 10% 
heat Inactivated AB aerum wltn or without a previously 
determined optimum dose oE 2ug/ml of 
phytoheeaqglutlnln (PHX) (Wellcome Reagents,
Beckenham, England). T lymphocytes, 2xl0®/well, were 
incubated alone or t'ith uninfected or HCFV-infected, 
LPS-stlmulated or unetieulated monocyte* that had been 
cultured for 3 days. Maximum stimulation of T 
lymphocytes by PHX occurred after a further 72 hrs in 
culture. Lymphocyte stimulation was measured by the 
addition of 0.5uci of t^Blthymidine (specific 
activity, 19.3 cl/mmol: Hew England Nuclear Corp., 
Boston, MX, USX) to each well IS hr before harvest. 
Cells were harvested with a multiple automatic 
harvester (MASH II, Microbiological Associate 
Bioproducts) on glass fibre filters (Whatman, Clifhon, 
N.J.), air dried and immersed in toluene scintillation 
fluid. (3H Jthymidine incorporation was assessed by 
liquid scintillation counting for 10 ain in a liquid 
scintillation counter (Packard Instrument Co., Downers 
Grove, III) and expressed in dpm. xll experiments were 
performed in tripii- ,-te and results averaged.
2.8.0. Immupoflouregence for detection of HCMV 
liiimediate-Earlv Antigen Expression
tmmunoflouresence for detection of HCMV immediate -
early (in) antigen expression in infected periphe.il 
blood monocytes and ML-3 cells was assessed on 
cytocentrifuge preparations. Slides were sir dried and 
fixed sequentially in the following solutions: 3.7% 
formaldehyde for 5 min at room temperature, methanol 
for 2-4 min at -20*C and acetone for 2 min at -20eC. 
Fixed monocytes were then blocked with 10% human AB 
serum for 30 min at 37 t  to prevent non-specific 
binding of monoclonal antibody to monocyte Fc 
receptors. Slides were then rinsed in PBS and incubated 
for 1 hr at 37 °C with a monoclonal antibody recognising 
the major 72-kilodalton (kDa) immediate-early protein 
of HCMV (a gift from L.Goldstein, Fred Hutchinson 
Cancer Research Centre, Seattle, Washington, OSA). 
Control slides were incubated with PBS + 5% BSA instead 
of monoclonal ant. v>dy, Slides were then rinsed 
thoroughly in PBS and incubated with FITC labelled 
rabbit antimouse immunoglobulin (Capper 
Labs.,Cochranville, PA.,USA) at 37 t  for I hr. Slides 
were rinsed thoroughly in °BS and stained cells 
observed with a Leitz Weitzlac Oialux 20 microscope 
(West Germany).
2.9.0. Assay for Functional Interleukin 1 Activity
The assay for detection of functional IL-1 activity is 
based upon the enhancement of murine thymocyte
proliferation by IJ»-1 in response to suboptieal 
concentrations of the mitogens pha ol Con a (sery et 
al., 1172). Single cell thymocyte suspensions were 
pr e* b* eeeptlcally teaelng the thymus gland# of 6 
<eek old Balb-c ml e. The larger clumps of cells 
were allowed to settle, and the single cell suspension 
pellet*# by meatclfugatlou at 1000 g for 10 mln.
C*lla *pr# washed twioe In PSS and reeuspended in RPMi
1640 containing 5* eat inactivated PCS, 2.5xl0~2 M 
2-mere*pteethanol, 2 m# glutamine and 2ug/ml p#A. 
Viability was assessed by try;an blue dye exclusion. 
Aliquots, .001#, of the cell suspension containing 
10® cells were plated into the wells of 96 well 
tissue culture plates (falcon, Oxnard, CA, CSA). 
culture supernatants (lOOwl) from infected or 
uninfected, stimulated or unstimulated monocytes that 
had been cultured for 3 days post infection were added 
to the wells. Thymocyte proliferation was maximal after 
96 hr. Cultures were pulsed with 0.Suci of 
I3h)thymidine per well for the final 16 hr wf 
incubation, cells were harvested with a multiple 
automatic harvester, and [ ] tnymidine incorporation 
assessed by liquid scintillation counting. Experiments 
were performed in triplicate and the mean 
disintegrations per minute calculated.
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2,9.1. Detection of IL-1 S using ELISA
LPS-stimulated or unstimulated monocytes were infected 
or mock-infected as described above and then cultured 
for Id after infection. After 24 hr, supernatants were 
removed, replaced with fresh medium and this 
supernatant collected after a further 24 hr 
(representing ld~2d mediator production). Fresh 
supernatant was added and removed after an additional 
24 hr (representing 2d-3d mediator production).
Quantitative measurement of secreted 1L-1B in culture 
supernatants was performed using an IL-1B ELISA kit 
(Cistron Biotechnology, Pine Brook, NJ, USA) following 
instructions given by the manufacturers.
2.10.0. Addition of Pure IL-1 or IL-1 Containing 
Supernatant to HCHV-lnfected Monocytes
Pure IL-1 (a gift from L. Traub of the Immunology 
Department, South African Institute for Medical 
Researchi was serially diluted from an Initial 
concentration of 4U/ml using 0.1% bovine serum albumin 
(BSA) in PBS. IL-1 conditioned supernatant obtained 
from LPS-stimulated monocytes was diluted 1*2, 1:4 and 
1:16.
Stimulated or unstimulated, HCMV-infected or uninfected 
monocytes were cultured in vitro for 3 days. After 3 
days, culture medium was removed and cells washed with 
RPMI 1640.
T lymphocytes, 100 it, (10* cells/ml! In RPMI 1640 
supplemented with 10% heat inactivated AS serum and 2 
yg/ml PHA, were added to wells containing monocytes 
<105 lymphocytes/well). Pure IL-1 or IL-1 conditioned 
medium serially diluted in RPMI 1640, 100U1, was added 
to the T lymphocytes « a total of 290u1 added per 
well. Control wells consisted off monocytes, T 
lymphocytes and PHA, with no exogenous IL-1 added.
Infected and uninfected monocytes were incubated for a 
further 3 days in the presence of aucologow T cells 
and PHA, with or without various concentrations of 
IL-1. Lymphocyte stimulation was assessed after 72h by 
the addition of 0.5 uCi of (^Hlthymidine (specific 
activity, 19.3 Ci/mmul) per well for 16 hr. Cells were 
harvested using an automatic cell harvester and 
incorporated radioactivity asured by liquid 
scintillation counting and expressed as mesn dpm for 
triplicate samples.
2.11.0. Detection of Intracellular IL-16 in Monocytes 
and ML-3 Cells by Immunoblottin-3
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2,11.1. Protein Isolation
BCMV-infected or mock infected ML-3 cells and 
peripheral blood monocytes were harvested at 24 hr and 
72 hr post infection and washed three times with PBS. 
approximately 5 x 10® cells were extracted with 
200 hi of lysis buffer consisting of 0.05 M iris 
hydrochloride, 0.15 M NaCl, 0.1% SDS, 1% sodium 
deoxycholate. It Triton x-100, 0.1 mM phenylmethyl 
sulfonyl flouride for 30 min on ice. The cells were 
disrupted by 20 strokes in a 1 ml Bounce homogenizer 
(Wheaton, Mellvtlle, tU, OSA) and then centrifuged at 
10 000 g for 20 min. The supernatant was decanted and 
stored at -ZO'C.
The Bio-Rad protein assay was employed, which is based
on the shift in the absorbance maximum of Coomassic 
Brilliant Blue (CBB) G-250 from 465 nm to 595 nm when 
binding to protein occurs (Bradford, 1976). The protein 
content of samples solubilised in lysis buffer could be 
accurately estimated by this method. In all cases, a 
standard curve of absorbance versus concentration of 
protein was drawn up for BSA in the concentration range 
of 0-50 mg/ml protein and the unknown sample protein 
concentrations were read off the curve.
2.11.2. Polyacrylamide Gel Electrophoresis
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Proteins from ML-3 cells and monocytes were analysed by 
SBS-polyacrylamide gel elecrophoresis by the method of 
Laemmli (1970), The slab gels used in this work 
consisted of a running gel (appendix 3) of 12% 
acrylamide and a 4% stacking gel (appendix 3). A 
Bio-Rad vertical slao gel apparatus was used. 
Electrophoretic separation was carried out in a 
continuous Tris-glycine buffer system at a pH of 8.3 
(appendix 3). Thirtyu1 of sample containing 20-25yg 
of protein was mixed with 30yl of 2X sample buffer 
(appendix 3) and haated to 95°C for 5 rain. Two UL of 
bromophenol blue tracking dye solution (appendix 3) was 
added to each sample. The samples were loaded onto the 
gel and electrophoresis performed at ro*" temperature 
for 5 - 6 hr it 100 V.
2.11.3. Western Blot Analysis
Proteins separated on SDS-polyacralamide gexs were 
transferred electrophoretleally onto nitrocellulose 
sheets by a modification of the original procedure 
described by Towbin et_ a 1. (1979). The electrode hufter 
used for transfer was composed of 25 mM tris bac:, iW2 
mM glycine and 20% methanol (v/v) at pH 8.3. A sheet of 
nitrocellulose (0.45ym pi size, Schleicher and 
Schuell Inc., Keene, NH, uSA) and sheets of Whatman's 
number 1 filter paper were soaked with electrode
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buffer. The gel was rimed with electrode buffer and a 
sandwich prepared with the following successive layers
(I) two sheets of filter paper
(II) the nitrocellulose sheet
(ill) the SDS-polyacrylamide slab gel with the stacking 
gel removed
(Iv) two more assets of filter paper
Care was taken to remove all sir bubbles between *ne 
gel and the nitrocellulose. The assembly was placed in 
a Bio-Rad electrophoretic transfer apparatus with the 
gel facing the cathode. The buffer tank was filled with 
transfer buffer to cover the gel and elecrophoretlc 
transfer performed at 200 nA for 16 hr at 4“ C.
The nitrocellulose sheet win wa-hod in PCS at rona 
temperature for 10 min with gentle agitation. To 
prevent non-specific background binding, the filters
used in the transfer were 'icubated at 37 eC for 1 hr in 
PBS containing It BSA. This blocking solution was 
aspirated and replaced with a 1:100 dilution of rabbit 
anti-human IL-1? polyclonal antibody (Cistron 
Biotechnology, Pine Brook, NJ, USA) in 10 ml of 
blocking solution. Incubation was continued for 1 hr at 
376c with gentle agitation. The immunoblotted filter 
was ashed tnree times for 10 min each with PBS 
containing 0.05% Tween-20.
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Goat antirabbit iaSunoglobulin alkaline phosphatase 
conjugate (Southern Biotechnology Associates, 
Birmingham, AB, 08») at a 1,1000 dilutioi in blocking 
solution tat usej for detection of IL-S antigen. The 
filter waa incubated with the secondary antibody f j t 1 
hr at 37*C with gentle agitation and then washed three 
times in PBS containing 0.05% Tween-20. The colour 
indicator aubetrate was prepared as followsi 3.3 mg 
5-bro«to-4-chloro-3-lndolyl phosphate £-tolutdine salt 
(BCIP) was dissolved in 1 ml H.N-dinethyl-formaalde 
(BMP) and 6.6 mg nitro blue tetrazolium (HBT) dissolved 
in 50% IMP in water. One ml of each reagent was 
sequentially a M e d  to 200 ml of a lOOtnM Tris HC1 (pH 
9.5), 100b* Nad, 5 »M * ;C12 solution and immediately 
5d. ' no the filter. The filter was Incubated at room
gentle agitation until a purple colour 
mini. The filter was then transfer « 
to aMwa##p*#@ntalmer containing water to halt colour 
develop##**, filter# were air dried and stared between 
abeet# *# filter paper in the dark.
X.l'.O. **A PKOC D0BE8
2.12.X. of Total *NA from ML-3 Cell#
PMA-#tl#*l#te* or uastlsulated ML-3 cells were infected 
or moth i#(mct#d with HCMV and total RNA extracted a. 
1,1 ### # #ay# poet Infection. RNA was isolated by tne
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guanidine ieothiocyanate method of Chirgwin et al. 
(197?). Celle were harvested by centrifugation and 
wash id twice with PBS. The cell pellet was resuspended 
in 3.2 si of 4 M guanidine ieothiocyanate solution 
(appendix 4) and the suspension vortexed for 20 secs. 
The cells were homogenized at medium speed for 30 secs 
using a Polytron homogenizer (Brinkman Instruments 
Inc., Mestbury, NY, OS*!. The lysate was carefully 
layered onto 1.2 ml of a 5.7 M CsCl solution in a 5 ml 
centrifuge, tube (Beckman Instruments Inc., Palo Alto, 
CA, USA) and centrifuged for 18 hr at 36 000 rpm at 20’ 
C in a SW 55 rotor (Bec'.man). The supernatant was 
carefully removed and the RNf. pellet resuspended in a 
total of 400)4. of diethyl pyrocarbonate (DEPC) treated 
water (appendix 4). The RNA solution was transferred to 
a 1.5 ml microfuge tube and 40vl of 3 h sodium 
acetate, pH 6, added to the RNA preparation followed by 
900 ul of 95% ethanol. The suspension was thoroughly 
mixed by vcrtexing. RNA was precipitated at -20°C 
overnight and the suspension spun in an Eppendorf 
microfuge for 30 mi.i. The supernatant was discarded and 
the RNA pel let dried in a vacuum centrifuge (savant 
Instruments, Hicksville, NY, USA). The pellet was 
resuspended in 50 u 1 of DBPC-treated water and the RNA 
concentration determined by O.D at 260 nm.
2.12.2. Elecrophorettc Separation of RNA and Northern
Blot
Total RHA extracted by the guanidine isothiocyanate 
method was resolved by agarose gel electrophoresis in
the presence of formaldehyde according to the method of 
Lehrach et a_l. (1977). Agarose, 2g, (BRL,
Gaithersburg,MD, USA) was dissolved ry heating in 160 
ml distilled water and cooled to 50aC before addition 
of 20 ml of 10X MOPS buffer (appendix 4) and 20 ml of 
37% formaldehyde. A horizontal gel electrophoresis 
apparatus was used (Hoefer Scientific Instruments, San 
Francisco, CA, USA). Equal amounts of each RNA sample 
(20 ig) were applied to wells in 5 mm thick agarose 
formaldehyde gels. RNA was denatured in 25-30U1 of 
loading buffer (appendix 4) by heating to 5# C for 15 
min. Elecrophoretie resolution was carried out using 1 
X MOPS as the runninj buffer at 4eC for 18-20 hr at 
35-40 V per gel.
Total RNA resolved by agarose gel electrophoresis inco 
28 S rRNA and 18 S rRNA species was transferred onto 
nitrocellulose sheets using the procedure described by 
Maniatis et a_l. (1982). Nitrocellulose (0.45# pore 
size, Suheicher and Schull) and three pieces of Whatman 
3MM paper cut to size were wetted in 2 X SSC buffer 
(appendix 3). Whatman 3MM paper was wrapped around a 
olass plate and the plate placed on a support in a 
large baking dish. The dish was Cil,.ed with 20 X SSC to 
just below the top of the support and a sandwich
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prepared on the glass plate with the following 
successive layers :
(i) two sheets of Whatman 3MM paper cut to the size of
the gel and soaked in 2 X SSC
(ii) the agarose gel
(ill) a nitrocellulose sheet cut 1-2 mm smaller than 
the gel and soaked in 2 X SSC
(iv) one sheet of Whatman 3MM paper snaked in 2 X SSC
(v) paper towels cat to the size of the nitrocellulose 
to a height of 5-8 cm
This arrangement allowed for a flow of liquid from tne 
reservoir through the gel so that the RNA was deposited 
on the nitrocellulose. Transfer was complete with in 12 
hr. The paper towel stacks and paper sheets were
removed and the nitrocellulose sheet placed between two
sheets of 3MM paper and baked for 2 hrs at 80 "1 under 
vacuum.
2.12.3. Dot Blot Analysis of Monocyte RNA
LPS-stimulated or unstimulated monocytes were infected 
(5 pfu/celi) or mock-infected with HCMV and total RNA 
extracted at 1,2 and 4 days post-infection using a 
modification of the method of White and Bancroft 
(1982).
Monocytes were cultured in 15 ml polypropylene tubes at 
a concentration of 1-2 x 10® cells/ml and transferred 
to Eppendorf microfuge tubes fcr RNA extraction. Cells
were harvested and washed twice with DEPC-treated PBS. 
Two hundred#1 of lysis buffer (appendix 4B) was then 
added to tne pellet. The cells were sheared using a 26G 
needle attached to a 1 ml syringe and the cell lysate 
incubated at 37°C for 15 min. Phenol:chloroform (1:1), 
200 yl, was added to the lysate, the suspension 
vortexed and allowed to stand at room temperature for 3 
min. The two phases were separated by spinning in an 
Kppendorf microfuge for 2 min. The aqueous phase was 
transferred to a new tube and extracted with 0.5 ml 
chloroform. The suspension was vortexed and spun for 2 
min in an Eppentiorf microfuge. The aqueous phase was 
collected and 0.5 ml cold ethanol added. The RNA was 
allowed to precipitate at -20QC overnight. The ethanol 
precipitates were spun in an Eppendorf microfuge for 10 
nun and th-> ethanol decanted. RNA pellets were dried in 
a vacuum centrifuge for 5 min. The pellet was dissolved 
in 100 y! of TE buffer (pH8} by occasional vortexing.
One hundred 4 of 4 M LiCl^ was added and the tubes 
placed at 4°v overnight. Samples were centrifuged at 12
000 rpm for 20 .Tin in rn Eppsndorf microfuge and the 
supernatants carefully removed. The RNA pell'?t was 
resuspended in 10 yl oc DEPC treated water, 6yl of 20X 
SSC and 4yl of 37% formaldehyde. The samples were 
heated at CO =C for 15 min and 80 va of 15X SSC added to 
briny the volume to lOOyl. RNA was serially diluted 
two-fold in 15X SSC and applied to nitrocellulose. The 
dot blob ma,J fold (Schleicher and Schuell Inc., Keene, 
NH, USAj was assembled as fol ows : Whatman 3MM paper
and 0.45yn nitrocellulose were cut to the size of the 
apparatus. The nitrocellulose was soaked first In 
DBPC-tteated water followed by 15X SSC.IMs was placej 
on top of the Whatman 3MM paper also soaked with 15% 
M C .  Th* wells were rinsed twlc* witk 19: «#C. The RMA 
samples were applied to the wells after which they were 
rinsed twice with 15X SSC. The nitrocellulose filter 
was baked in a vacuum oven at 80* C for 2 hrs.
2.12.4. Oligonucleotide and cONA oeobes
2.12.4.1. Kinase Labelling of S' ends of 
Oligonucleotide DMA Probes
Oligonucleotide probes for IL-18, CSF-1, TNFa, lysozyme 
and 8-actin were a gift from E. Kswssskl and ware
synthesized at Cetus Corporation (San Francisco, CA, 
USA) from published sequences: IL-16 (March et al■, 
1985), CSf-1 (Xawasaki et si., 1935;, u (Wang et 
al., 1*851, lysosymt (synthesised fro* a consensus 
sequence) and 8-actln tPonte et si., 1*84).
The 5' ends of the DNA probes were labelled with T* 
polynucleotide kinase In a ri'ction mlxt'ire conta'nlnr 
1-50 pmoles of daphosphorylated DNA ( 5' ends), 10ul 
of 10X kinase buffer I (appendix 4), ISO *C1[ ^^Pl 
ATP ( speclfl' actlvlty-3000 Cl/mmole ), 10-20 u-.it* T4 
polynucleotide kinase and water to 50pl. The reaction
nix was incubated at 37 K  fox 30 min, FollOWins 
incubation, 2ul of 0.5M EDTA was added, the 
extracted once with phenol/chloroform (1:1) attsi 
precipitated with ethanol. The DNA was rediSSSlwaS iii 
50U1 of TE buffer (pH 9) and labelled DHA separate 
from unincorporated 32F-ATP by separation th oufb 
small columns of Sephadex G-50.
Sephadex G-50 columns were set up as follows * fctld 
bottom of a 1 ml syringe was plugged with sterile §1&8S 
wool. In the syringe a column ( 0.9 ml bed VOlttile ) Wes 
pre ared using Sephadex G-50 equilibrated in fB (p*  ^t 
containing 0.1 M NaCl. The syrir inserted
p l a s t i c  centrifuge tube and spi 000 rpw
for 10 min. Sephadex was added .entri!
repeated untilthe column volun ' '. 1 clamft
was washed twice using 200 ul of T2 tc : T'a DNA
was a p p l i e d  to the column in a * -.aj. v >-"1.1 al.
The column was s p u n  a t  2 000 rpm i or ' ifi,' And i 3# 
effluent from the syringe collect rr. l,’ . d capped 
Eppendor f tube. The vnincorpcr ->d 3 'P dN,m » te#&imed 
in the syr i
2.12.4.2. Nick Translation of cDHA probes
Three cONA clones, MAD-2, MAD-6 a n d  MAO-9 ***#
by Dr. Stephen Haskill, Chapel Hill, NC, OSA, While 
some of the above studies were being carried out in his
laboratory. The clones were induced in monocytes in a 
rapid response to adherence. These cDN& elopes were (i) 
MAD-9, which is identical to a prointlammatory protein 
that is chemotactic frc human neutrophils. This protein 
is known as n.onoryte-d*rived neutrophil chemotactic 
factor (MDNCP) purified by yoshimura et (19871 or 
as p.eutrophil-activating factor (NAP) (Psveri et al., 
1988) or as neutrophil-activating protein (NAP-1) 
(Larsen et al., 1989), (ii) MAD-2 shows 88% nucleotide 
and amino acid homology with a melanoma stimulatory 
growth factor called h-gro or MGSA (Anisowicz et al., 
19871 Richmond et al., 1988) and (Hi: MAD-6 whose DMA 
sequence shows no homology to know gene,.
The cDNA clones were labelled with [a-^2P] in a nick
translation reaction containing 5 u 1 cf 10X 
nick-translation buffer, 1 yg of DMA, 1 ul of a 1 mM
solution of dNTPs, 100 pmoles cf (a -^2P]dNTPs in a
total reaction volume of 44 ul. The reaction mixture 
was chilled to 0 °C before addition of 0.5 yl <-t a DNase 
I solution (0.1 yg/ml). Alter vortexing, 5 units of E. 
coll DMA polymerase I (Promega Biotech., Madison, WI, 
USA) was added and the reaction mixture incubated at 16° 
C for 1 hr. The reaction was stopped by addition of 2
4 of 0.5M EDTA -nd the nick-translated DNA separated 
from the unincorporated dNTPs by chromatography on a 
Sephadex G-50 column.
84
A Sephadex G-50 column wa< prepared in a disposable 5 
ml borosilicafce glass pipette . The DNA sample in a 
volume of 200v 1 was applied to the column and a 
reservoir of TE (pH 8) connected to the column so 
chatthe flow rate was 0.5 ml/min. The leading peak of 
radioactivity consisted of nucleotides incorporated 
into the DMA. These fractions were pooled and stored at 
-20 s C.
2.12.5. Hybridization
Baked nitrocellulose filters were prewashed for 1 hr at
42° C in a solution containing 0.1 M EDTA (pH 8), 5 ft 
NaCl, 1 ft Tris-HCl (pH 8) and 10% SDS. This was 
followed by prehybridization at 42 9C for ? hr in 
hybridization fluid containing 50% formamide, 5X JSC,
5X Denhardts, 0.1% SOS, 10 mM NaH P04 and 100ug/ml 
salmon sperm DNA. [^2P]-labelled oligonucleotide 
probes or cONA probes were then added to the 
hybridization fluid at 10 6 cpm/ml and filters 
hybridized for 18 to 24 hrs at 27 ac for oligonucleotide 
probes and 42° C for cDNA probes. Filters were washed to 
a final stringency of 0.2X SSC as follows ;
(!) 6 X SSC, 20 mM NaH PO*, 0.1% SDS for 10 min at 
27° C.
(11) 2 X SSC, 20 mM NaH K>4 for 20 min at 42°C.
(iii) 1 X SSC, 20 mM NaH P04 for 20 min at 42 c.
(iv) 0.2 X SSC, 20 mM NaH P04 for 20 min at 42° C.
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Filters were exposed to Kodat XAR X-ray film at -7CP C,
2.13.0. In situ Hybridization
2.13.1. Cell Culture and Fixation
Monocytes were isolated by Ficoll-Eypaque separation 
and 2x10® cells/well adhered to an 8 chamber Labisk 
culture slide for 30 min at 37*C. After removal of 
non-adherent lymphocytes, the remaining adherent 
monocytes were incubated overnight in RPMI 1640 
supplemented with 10% AS serum. Mononcytes were then 
infected with HCMV at a MOI of 5 pfu/cell or mock 
infected with supernatant from uninfected fibroblast 
cultures as described previously.
At 1,2 and 4 days post-infecton, culture medium was 
removed and cells rinsed with RPMI 1640. Cells were 
fixed in 4% paraformaldehyde/PBS for 15 min at 4°C 
followed by a second incubation at room temperature for 
15 min. Cells were then gently rinsed twice with PBS 
with 5 inM MgClg added (PBSM). Slides were dehydrated 
at 22° C as follows: 70% ethanol for 3 minutes, 95% 
ethanol for 3 minutes, 100% ethanol for 3 minutes.
2.13.2. Hybridization
Slides were incubated sequentially in PBSM and 0 >M
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Tris-HCl (pH 7.5), 0.1M glycine for 10 min at room 
temperature. Labelled cRNA probe was resuspended at 
3xl06 cpm/ml in hybridization buffer containing 50% 
deionized formamide, 0,6 M Had, 10 mM Tris-HCl pH 7.5,
1 mM EDTK, 1% SDS, 10 mM dithiothreitol (DTT), 10% 
polyethylene glycol (VEG-6'100), I X  Denhardt's solution 
and 0.25 mg/ml E.coli t R N A .  A 15 yl volume of this 
solution was applied to each chamber of the slide and 
covered with a coveralip. Slides were incubated at 5? C 
for 20 hr in petri dishes c o n t a i n i n g  moist Whatman 
filter paper circles ( w e t t i n g  solution contained 50% 
v/v deionized formamide, 50% v/v distilled water and 
100 mg/ml PEG-8000). Petr i dishes were sealed with 
p l a a t i c  t a p e .
Coverslips were removed by gently dipping slides into 
PBSM. Slides were i n c u b a t e d  for 30 min a t  37 "c in a 0.5 
M NaCl, 10 m.. "'ris-HCl (pH 8) solution c o n t a i n i n g  20 
mg/ml RNAse A to facilitate digestion of n o n - h y b r i d l zed 
ssRNA. Slides were then washed in 0.5 M N a C l ,  lOmM 
Tris-HCl pH 8 at 37 °C for 30 min followed by four 
stringency washes as follows
(!) 2X SBC, 50% forma,nide, 10 mM DTT for 30 min at 55° C 
1 1 1 )  IX SSC, 50% formamide, lOmM DTT for 30 min at 59 C
(iii) IX SSC, 50% formamide, lOmM DTT, 0.05% Triton 
*-100 for 30 min at 37°C.
(iv) IX SSC, 50% formamide, lOmM DTT, 0.05% Triton 
X-100 for 30 min at 5 5 » C .
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Slides wero then dehydrated with increasing 
concentrations of ethanol and air dried.
2.13.3. \utoiadlography
HTB2 nuclear track emulsion (Eastman Kodak Co., 
Rochester, NY, USA) was dissolved in 0.6 M ammonium 
acetate which had been prewarmed to 42°C. Slides were 
coated with emulsion solution which was kept at 42 C in 
a waterbath. After air drying for 1 hr, slides were 
exposed at 4°C in a light tight Sox containing 
dessicant chips for 5-10 days.
2.13.4. Development and Counterstaln
Slides were warmed to room temperature and developed in 
Kodak D19 developer for 1 min and fixed in Kodafix 
(Eastman Kodak' for 5 min at room temperature. After 
two washes in distilled water for 5 min each, slides 
were c-'unterstained as follows:
(i) Gil's haematuxylin, No.2 (sigma Corp.,St.Louis,
MO., USA) for 5 secs followed by three 10 second and 
one 5 minute wash in distil'ed water
(11) water soluble eosin, 0.5% w/v, (Sigma) for 90 
seconds, followed by three 10 second and one 5 minute 
wash in distilled water.
Slider, were dehydrated in increasing concentrations of 
ethanol followed by three xylene dips of 3 minutes
each. For viewing, slides were mounted in Permount.
2.13.5. cRHA probe labelling
For the generation of sense and antisense RNA probes, 
the full length 1.8 kb XL-18 cDNA was subcloned into 
the Bam HI site of the plasmid pGEM-blue (Promega 
Biotech, Madison, M I ,  USA I in two different 
orientations. Run-on t r a n s c r i p t s  of the template cDNA  
w e r e  synthesised u s i n g  T7 rna polymerase in a 20 u 1 
reaction mix c o n t a i n i n g  0.2yg of l i n e a r i z e d  template 
DMA, 40 BM iris (pH 7.5), 6 mM M g C l _ ,  2 mM
spermidine, 10 mmM Nad, 10 mM DTI, 2.5 mM each of A T P ,
CTP a n d  0.04 mM ^^S-a-UTP (650 Cl/mmol; Amersham
Corp., Arlington H e i g h t s ,  XL, USA). The l a b e l l e d  SNA
was e x t r a c t e d  with p h e n o l:chloroform (1:1), e t h a n o l  
precipitated and resuspended in hybridization b u f f e r .
2.14.0. Transfection Studies
2.14.1. Plasmid DMA
Plasmids 3M-AT and 3MB-AT w e r e  obtained from Dr. p. 
A u r o n ,  MIT, Cambridge, MA, USA. These plasmids 
containing putative human proIL-18 gene regulatory 
r e g i o n s  were derived by i n s e r t i o n  of each of two 
different fragments derived from the BDC-454 c l o n e  
described by Clark a t  al. (1986). The Aval/ TagI
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fragment located between positions -512 and +12 
(Fragment AT) was treated with the Klenow fragment of 
B. coli DNA polymerase and inserted by blunt-end 
ligation into the pSVCAT-3M plasmid described by 
La:mina et al„ (1984). Therefore the resulting plasmid 
contained proIL-18 genomic DNA corresponding to 
positions -512 to +14 for AT (Figure 3). In addition, 
these fragments contain a TATA sequence at position -31 
as well as other features which have been described by 
Auron et aJL. (1989).
The HCMV immediate-early gene region plasmids 
pBDlOlSVl, PHD1Q1SV2 and 10142 (Davis et al., 1987) 
were constructed in the laboratory of Dr. Eng-Shang 
Huang. In pHDlOlSVl, the region 1 and region 2 of the 
HCMV IE region are under control of the HCMV IE 
promoter with the SV40 enhancer located further 
upstream. Plasmid pHD10lSV2 is identical to pHDlOlSVl 
except that the 5.5 kb Bam HI fragment containing 
region 2 has been deleted. Plasmid 1C142 has the exon 
sequence of region 1 deleted.
2.14.2. Plasmid Purification
An overnight culture of E.coli containing plasmids 
3M-AT and 3ME-AT respectively, was grown at 37°C in 40 
ml LB medium (appendix 5) supplemented with 50ug/ml 
ampicillin. The culture was added to 1 litre of
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minimal medium (appendix 5) and grown with shaking in a 
Gfillenkamp orbital shaker until the optical density 
(OD) at 600 nm was 0.6. When this OD was reached, 1 ml 
of a 100 ig/ml chloramphenicol solution was added to 
amplify copy nuir' r of the plasmid while stopping 
bacterial replication. The flask was shaken at 120 rpm 
overflight at 37 °C. Cells were spun down at 6000S for
5 min at 4°G. The pellet was resuspended in 10 ml of a 
solution containing 0.05 M Tris-HCl# 0.01 M BDTA and 
20% sucrose together with 1 ml of 50 mg/ml freshly made 
lysozyme solution. Twenty ml of a solution containing 
0.2 N NaOH and 1% SDS was tten added with gentle mixing 
and the tube incubated on ice for 15-20 min. Fifteen ml 
of a 3 M NaAc solution was then added and the tube 
swir.’.ed vary gently. The suspension was incubated on 
ice for a Eurthei 15 min. The white precipitate was 
spun down at 10 000 g for 20 min. The supernatant, was 
extracted with an equal volume of phenol:chloroform 
(1:1) and the phases separated at 5 000 g for 10 min. 
The upper aqueous phase was transferred to a new tube, 
extracted with an equal volume of chloroform and the 
phases separated by centrifugation. The aqueous phase 
was removed and one tenth of this volume of 3M NaAc 
plus 2 volumes of 95% ethanol were added to the aqueous 
phase. The DNA was precipitated for 1 hr at -20": and 
centrifuged at 10 000 g for 30 min at 4°C. The pellet 
was dried at room temperature for 25 min. CsCl was made 
up at 1.58g/ml in TE buffer and the refractive index
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adjusted to 1.395-1.400. The DNA pellet was r e s u s p e n d  ,d 
i n  36 ml of CsCl solution and the suspension 
t r a n s f e r r e d  to Beckman qulck-seal tubes (VTi 50; 25 x 
89 am tube). The remaining volume of the tube was 
completely filled with e t h i d l u m  bromide in TB buffer 
(10 mg/ml), the tubes sealed and spun in a Beckman VTi 
50 vertical rotor at 45 000 rpm for 18 hrs. After 
centrifugation, the lower band containing plasmid DMA 
was removed using a syringe needle attached to a 
syringe. T h e  collected material was made up to 36 ml 
with CsCl a n d  banded a second time as before. The 
plasmid band w a s  removed in the same way and an equal 
volume of n-butanol a d d e d .  This w a s  mixed well and the 
upper butanol l a y e r  d i s c a r d e d .  This e x t r a c t !  . was 
repeated t h r e e  more times until a l l  traces o f  ethidlum 
bromide were removed. The lower aqueous phase was 
t r a n s f e r r e d  t o  a 30 ml g l a s s  t u b e  a n d  extracted once 
with phenol:chloroform (1:1) a n d  once with chloroform. 
DMA w a s  ethanol precipitated and centrifuged at 10 000 
rpm for 30 min at 4°C. T h e  pellet was d r i e d ,  
resuspended in 1 ml s t e r i l e  d i s t i l l e d  water and the CD 
at 260 nm m e a s u r e d  to determine the UNA concentration.
2.14.3. DMA Transfections
Plasmid DMA was reprecipitated with 3 M ammonium 
acetate, pF 6, and 95% ethanol prior to transfection 
and resuspended in sterile distilled water at a
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adjusted to 1.395-1.400, The DNA pellet was resuspended 
in 36 ml of CsCl solution and the suspension 
transferred to Beckman quick-seal tubes (VTi 50; 25 x 
89 mm tube). The remaining volume of the tube was 
completely filled witi ethidium bromide in TE buffer 
(10 mg/ml), the tubes sealed and spun in a Beckman VTi 
50 vertical rotor at 45 000 rpm for 18 hrs. After 
centrifugation, the lo ;er band containing plasmid DMA 
was removeu using a syringe needle attached to a 
syringe. The collected material was made up to 36 ml 
wftt CsCl and banded a second time as before. The 
plasaud band was removed in the same way and an equal 
volume of n-butanol added, ihis was mixed veil and the 
upper butanol l a y e r  discarded. This extraction was 
repeated three more times until all traces of ethidium 
bromide were removed. The lower aqueous phase was 
transferred to a 30 ml glass tube a n d  extracted once 
with phenol:chloroform (1:1) and once with chloroform. 
DMA was ethanol precipitated and centrifuged at 10 000 
rpm for 30 min at 4°C. The pellet was dried, 
resuspended in 1 ml sterile distilled water and the OD 
at 260 nm measured to determine the DNA concentration.
2.14.3. DNA Transfections
Plasmid DNA was reprecipitated with 3 M ammonium 
acetate, pH 6, and 95% ethanol prior to transfection 
and resuspended in sterile distilled water at a
concentration of V  g/ul. PMA-stimulated or 
unstiraul&ted ML-3 cells were resuspended in F. .^640 
and 10% AB serum at a concentration o® 10^ cells/0,5 
ml for each transfection. ML-3 cells were transfected 
by electroporation with a Zapper Electroporation Unit 
(University of Wisconsin Medical Electronics Lab, 
Madison, wi, USA) at 1300 V. Celia and plasmid DNA were 
mixed in 0.5 ml RPMX 1640 and 10% AB serum in a 1 cm x 
1 cm plastic cuvette to which aluminium electrode 
strips were glu^d. After voltage was applied to the 
samples, the cells w re diluted into 10 ml RPMI medium 
containing 10% AB serum in 100 mm plastic petri dishes 
and incubated at 37°C in an atmosphere of 5% COg/SS# 
air.
2.14.4. Chloramphenicol Acetyltransferase (CAT) Assay
Cell extracts were prepared and assayed for CAT 
activity by a modification of the method described by 
Gorman et a_i., (1982). Cells were pelleted at 1 000 rpm 
and washed three times with PBS. The cell pellet was 
resuspended in 200 ul of 0.25 M Tris-HCl, pH 7.8. **C 
chloramphenicol (0.2 yCi? specific activity 60 
mCi/mmol? New England Nuclear, Boston, MA) was 
incubated with 0.7 mM acetyl coenzyme A (Sigma Chemical 
Co., st Louis, MO, USA) and 100 Ml of cell extract in a 
final volume of 120 yl of Tris-HCl, pH 7.8 for 60 min 
at 37 6c . Radioactive materials were extracted with 
ethyl acetate and the
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non-acetylafced chloramphenicol and acetylated reaction 
products separated by chromatography on thin layer 
chromatography (TLC) plates (Eastman Kodak Co.,
Rochester, NY, USA). Plates were exposed to Kodak XAR
X-ray film overnight.
2.15.0. Staining of ML-3 Cells and Flow Cytometry 
Analysis
The method was adapted directly from the method of Mann 
et al. (1987). Cells were washed in PBS and the cell 
pellet resuspended in 1.5 ml of PUS containing 4% 
paraformaldehyde. Cells were incubated at 37*C for 15 
min with constant agitation. The cell pellet was 
resuspended in PBS supplemented with 0.2% Triton X-100 
and incubated on ice for 10 min. The cells were then
pelleted by centrifugation, resuspended in PBS
containing 0.1% Tween 20 and 1% BSA and incubated on 
ice for 10 min. Cells were then resuspended in 5ul of 
anti-human IL-1B (IgGl' monoclonal antibody (1:20) 
(Cistron Biotechnology, Pine Brook, NJ, USA) or 5yl of 
the T cell specific Leu 2a, an antibody non-reactive 
for macrophages of the IgGl subtype (Becton 
Dickinson,Mountainview, CA, USA) and incubated for 30 
min at 37°C. The cells were then washed twice in PBS 
supplemented with 0.1% Tween 20 and 1% BSA. pelleted by 
centrifugation and resuspended in lOyl of a 1:20 
dilution of phycoerythrin conjugated goat anti-mouse 
IgGl (Southern Biotechnology Associates, Birmingham,
AB, USA) and
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incubated at 37* C for 30 min. Cells were then washed
twice a.'-d resuspended in PBS for flo«# cytometry 
analysis. Control cells were stained with secondary 
antibody only. Plow cytometric analysis was carried out 
on an ORTHO SYSTEM 50 operating with simultaneous 488 
and 514 nm excitation.
£, 16.0, Staining of Monocytes for Intracellular Ir.-18
CMV infected and mock-infected monocytes were cultured 
in Labtek slides and stained for the presence of 
intracellular IL-18 at various times post infection. 
Cells were washed in PBS and fixed in PBS containing 4% 
paraformaldehyde at 37°C for 15 min. This solution was 
replaced with PBS containing 0.2% Triton X-100 and 
incubated on ice for 10 min. Slides were then incubated 
in 3% hydrogen peroxide on ice for 10 min to prevent 
endogenous monocyte peroxidase activity, followed by 
incubation in a 50% v/v normal goat serum (NGS)/PBS 
solution to prevent non-specific binding of monoclonal 
antibody to Fc receptors on monocytes.
Slides were then incubated with anti-human IL-1B (IgG 
1) monoclonal antibody (Cistron Biotechnology, Pine 
Brook, NJ, USA) or Leu 2a (Becton Dickinson, 
Mountainview, CA, USA) for 30 min at 37 °C and then 
washed in three changes of PBS, care being taken to 
prevent drying at any stage. Peroxidase-conjugated
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incubated at 37° C for 30 min. Cells ware then washed 
twice and resuspended in PBS for flow cytometry 
analysis. Control cells were stained with secondary 
antibody only. Plow cytometric analysis was carried out 
on an ORTHO SYSTEM 50 operating witn simultaneous 488 
and 514 nm excitation.
2.16.0. Staining of Monocytes for Intracellular IL-1B
CMV I n f e c t e d  and rock-infecten monocytes were cultured 
in Labtek slides and stained for the presence of 
Intracellular IL-18 at various times post infection. 
C e l l s  w e r e  w a s h e d  in PBS a n d  fixed in PBS containing 4% 
paraformaldehyde a t  37 °C for 15  min. This solution was 
replaced with PBS containing 0.2% Triton x-100 and 
incubated on i c e  for 10 min. Slides were then I n c u b a t e d  
in 3% hydrogen peroxide on ice for 10 min to p r e v e n t  
endogenous monocyte peroxidase activity, f o l l o w e d  by 
incubation in a 50* v/v normal goat serum (NGSl/PBS 
solution to p r e v e n t  non-specific binding of monoclonal 
antibody to Fc receptors on monocytes.
Slides were then incubated with anti-human IL-18 (IgG 
1) monoclonal antibody (Cistron Biotechnology, Pine 
Brook, NJ, USA) or Leu 2a (Becton Dickinson, 
Mountainview, CA, USA) for 30 min at 37’C and then 
washed in t h r e e  changes of PBS, care being taken to 
prevent drying at any stage. Peroxidase-conjugated
9oat antisouse IgOl (Cappel Labs., Cochranville, Pa, 
CS&) (It50 ^U'ation) was then added for 30 min at 37* C. 
Sllden wet* Tlne«d in three changes oE PBS and 
Incubated In PBS cont.tnlr-* 0.021 dlamlnobenzldlne 
(DM) aud 0.01% hydrogen peroxide in was at room 
temperature for 5-10 min . After a final rinse in PBS, 
stained cells were counter#':ained with a G.1% solution 
of methyl *r**n.
96
3.0.0. RESULTS
3.1.0. Comparison of the degree of Infection of 
monocytes with a clinical isolate of HCMV and 
laboratory-adapted strain AD169
Unstimulated or LPS-stimulated monocytes challenged with 
H V strain AD169, which has been hirhly passaged in 
human fibroblasts, showed very low (0.01% - 0.1%) 
expression of HCMV immediate-early antigens, even when a 
multiplicity of infection of 5 pfu/cell was used. No 
differences in the number of IE-positive monocytes were 
observed for stimulated or unstimulated cultures. HCMV IE 
antigen expression in both unstimulated and 
LPS-stimulated monocytes was demonstrable in a higher 
percentage of monocytes after infection with the clinical 
isolate of CMV (Figure 4). The percentage of monocytes 
showing nuclear or perinuclear flourescence increased 
slightly with increasing MCI1s (Table 2). For an MOI of 
0.001 pfu/cell, as assessed by plaque forming assays on 
fibroblasts, 1-2% of infected monocytes showed detectable 
IE antigen expression, while for MOI's of 0.005 and 0.1 
pfu/cell, the percentage of monocytes showing 
flourescence varied between 3-5% and 7-9% respectively 
(Table 2). i,ideed,the results suggest that many more 
infectious virus particles were present in the clinical 
isolate, than could be detected by pfu assays on 
fibroblasts. When an MOI of 1 pfu to 1
oTable 2
Percentage of monocytes expressing the major 72-kDa immediate-early 
CMV polypeptide after infection with CMV strain ADI 69 or a  CMV isolate
CMV strain Multiplicity of infection ,
(PFU/cell)' E-3 p o # v e '(%)
ADI 69 0^ 0
1.0 0-0.01
5.0 0.01 -0.1
¥3474 -  84* 0.0(M 1 -2
0005 3 -5
0.(M 4 -6
0.1 7 9
' Multiplicities of Infection were estimated by plaque forming assays 
on fibroblasts.
t  Monoclonal antibody E-3 detects the major 72-kDa immediate-early 
CMV polypeptide. 
t CMV clinical isolate strain, V3474-84, was isolated from an adult with 
CMV mononucleosis.
*mo.iocy ’, as assayed on fibroblasts, was used, cell 
lysis of monocytes was observed (unpublished data). No 
expression of IE antigen was observed in uninfected 
monocytes (Figure 4), or in infected monocytes where 
only secondary antibody was used for staining.
Monocytes t h a t  were positive for IB antigen expre. ion 
were observed after 3 days in culture, and thereafter 
for as long as cells remained viable (7-9 days).
3.2.0. Suppression of T Lymphocyte Proliferation bv 
Autologous. LPS-stlmulated or unstimulated,
HCMV-Infected monocytes.
The number of unstimulated, uninfected monocytes needed 
to augment the proliferative response o f  purified 
autologous T cells was initially established (Table 3). 
For all donors tested the ratio o f  monocytesiT 
lymphocytes that gave a significant increase in 
lymphocyte stimulation was f o u n d  to be 1 , 5 (4x10* 
monocytes : 2xl05 T lymphocytes). Therefore for all 
subsequent experiments, a 1 i 5 ratio w a s  used, and the 
percentage stimulation of T lymphocytes in the presence 
of 4 x 10* unstimulated, uninfected monocytes taken 
as 100; all other i n c r e a s e s  or decreases detailed in 
Table 3 were calculated relative to this.
HCHV iBmediate-eatly antigen imsunofloutesence staining 
oE human peripheral blood monocytes Infected with HCMV 
isolate V3474-84. Immediate-early antigen was probed 
with monoclonal antibody 13 and indirect 
i imunofloureaence.
(a) HCMV IB antigen flouresence staini af 
uninfected monocytes. Cells were stained 
3 days after mock-lnfection (500X)
(b) Peripheral blood monocytes infected with HCMV 
isolate V3474-84 stained positive for IB 
antigen expression 3 days after infection <500X1
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Addition of t,PS-stimulated monocytes to autologous T 
lymphocytes, in the same ratios as for unstimulated 
monocytes, significantly augmented the T cell response 
to PHA when compared to unstimulated monocytes plus T 
cells, to I cellc alone (Table 3).
In the presence of both unstimulated and stimulated 
monocytes, the proliferative response of autologous T 
cells to PHA was significantly suppressed in the 
presence of monocytes infected with either the clinical 
isolate of HCMV or strain AD169 (Table 3). Pot both 
strains of virus, the higher the HOI used, the greater 
was the suppression of lymphocyte responses by infected 
monocytes. However, for all donors tested, monocytes 
infected with the clinical isolate were significantly 
more suppressive for T cell responses to PHA than were 
monocytes infected with strain AD169 ( PC.01 by 
Student's t test).
LPS-stimulated monocytes infected with either strain of 
HCMV at the same MOI's used for unstimulated monocytes, 
were significantly more suppressive for autologous T 
lymphocyte proliferation than were infected, 
unstimulated monocy :s. Infection of LPS-stimulated 
monocytes with the clinical isolate at MOI's of as low 
as 0.005 pfu/cell, completely abrogated the mitogenic 
response of T lymphocytes.
VaW»3
Suppiesslon ol T l y m p h o c y t e  pmj'fetoWon by l«-$!ntulc*ed ot umtlmulaled, CMV-tnlecled monocytes.
iH THYMKMNE INCOKPORA1ION' (ADFM  X 10 ’)
Cell Type CMV strain end MOICPfU/ce')
4 x lO* monocytes %s«mulaWon 8 x 10* monocytes % sMmv.'otton
T lymphocytes 
only (2 x W ) -
109.82-t 7.91 45.5 10962 ±  791 455
I lymphocytes and - 241.12 ±15 .15 io o t 275.17 d 13.66 114
unsHmuloted monocytes
AO *69 (O S) 17462 ± 1246 724 223.82 *  994 92.8
AD 169 (1.0) 110 46 ±10XH 45.8 133431 675 553
AD 169 (5S) . V3474-84 (0001)* 55.38 ± 8.25
22.9 60101 6.25 24.9
150.41 ± 9.52 62.3 23049 1 946 n sV3474-84 (0.008) 70.561 648 293 120.55 !  8.93 49.9
73474-84 (0.01) 28.81 1 262 11.9 40.33 ± 591 16.7
1 lymphocytes and 
IPS-sSnutoted
360.52 ± 24.9 150 380 27 1 26 1 158ADI69 (005) 210.21 4 15.12 871 201401 1432 834
ittonocyles AD169 (1.0) 31.491 497 139 21.201 201 88
AD 169 (5.0) 15.25 1 244 &3 10.01 1 1.04 42
V3474 W (0001) 300.61 ± 21 62 124.7 31065 1 21 08 123.8V3474-64 (0.005) 34461 409 14.3 45.63 :  5.12 189
73474-84(0.01) 22.39 1 221 93 25.42 *  2.71 10.5
' I “Mi m y n m o o e  :«pn«olion e  e x s w i w d  35 »ie m e a n  d p m  ol tuohcole soryAis > 1 SO 
t %  sMmulohon of I iyTT^jhocyte* tn Wte s m m c e  of 4*  10* un$Mrnulu«ed, urWiec^i 
m o n o c y N w  a nd PHA (Ttig'mt) is «Bpfe5»nied os 100%. All olh« p«cerrtoges are calculated 
retoUve to tNs value
t C M V  cllrticcri isolate shatn V3474-34 was teoic^d from tan ocfuft *#« C M V  nwnonvcleotis
0 n
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Differences in the degree of suppression that were 
observed for monocytes infected with either strain of 
HCMV, appear to be related to the extent of expression 
of the HCMV genome in infecte 3 cells, with monocytes 
infected with the clinical isolate showing oetectable 
expression of i ^ediate-early antigens and being 
significant.1/ more suppressive for T lymphocyte 
responses than monocytes challenged with strain AD16>.
3.3.0. Effect of HCMV Infection on Production of 
Functional IL-1 Activity by Unstimulat *d and 
LPS-stimulated Monocytes.
Infection of bo^.% unstimulated and stimulated monocytes 
with fith€r the clinical isolate of HCMV or strain 
AD169 abrogated their production of functional IL-1 
activity (Figure 5). Supernatants from unstimulated and 
stimulated HCMV-infected monocytes were significantly 
more suppressive for PHA-induced proliferation of mouse 
thymocytes than were uninfected monocytes. Uninfected, 
unr-imulated monocytes produced low levels of IL-1 over 
the three days in culture, but IL-1 activity of 
monocytes infected with either strain of HCMV was 3-5 
times lower than that of uninfected cells with the 
decrease in production of functional IL-1 activity 
being more marked in monocytes infected with the 
clinical isolate of HCMV (Figure 5). The net levels of 
IL-1 activity produced by monocytes stimulated with LPS
oc>
a ThymocytesThyme cytes : supernatant from 
uniniected m onocytes
Thymocytes f  supernatant from 
CMV infected m onocytes
200
180
: C lin ica l Isolate - M.O.I. -  0.005 PFU per ce ll 
: AD 169 fnefecfed m onocytes - M.O.I. -  1 PFU per cel? 
: AD 169 infected m onocytes -  M O.l. - 5 PFU per ce ll160
£  140% 120
40
SUPERNATANTS FROM UNSTIMULATEDSUPERNATANTS FROM
LPS-STIMULATED MONOCYTES MONOCYTES
RguwS
Effect o# CMV infection on production cW 114 activity by unstim ulated and IPS-stlm ulcied 
m onocytes
Supernatants from LPS-stimulated and unstlm ulaled, uniniected or CM V-inlecied m onocytes 
were assayed hn tt.u  conventional bioassay which measures t, e  a b ility  of 114 to  augm ent the 
PHA Induced proliferation of m ouse thymocytes. I l l actM ty is expressed as the mean 
incorporation of pH) thym idine in dpm  for trip lica te  sam ples t  1 SD.
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were considerably higher than those produced by 
unstimulated monocytes over the given culture period 
(Figure 5), The decreased production oi 1L-3 activity 
from stimulated monocytes as a result of infection by 
either strain of HCMV is more marked than for 
unstimulated cells, with levels irodueed ty stimulated 
infected monocytes being 17-35 times lower hen for 
stimulated, uninfected monocytes. Indeed, the 
supernatants of stimulated, infected monocytes did not 
augment [3H 1 thymidine incorporation at all.
3.4.0. Bffeet of Addition of 11,-1 Containing 
Supernatants or Pure IL-1 on T tvmpnocvta Proliferation 
in the Ptesenc 1 of HCHV-infected Monocytes,
Having observed the suppression of prrI!ierative 
responses cf T lymphocytes to PE?, in tfce presence of 
HCMV-inf ectod monocytes, as we I as a 4V-induced 
abrogation of functional IL-1 activity, rubeeguent 
experiments in this study investigated wiether this 
decrease was contributing to the h/.'.oresponalveneas of 
lymphocytes, as IL-1 is an eaa*ntlfl stoend signal for 
T cell activation (Oppenheim a o Gary, $82).
Addition of varying dilutions of pure !!,-! or IL-1- 
centaining supernatant to stimulated, HCHV-infected 
monocytes, completely restored the proliferative 
response of autologous T lymphocytes to similar levels
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measured in the presence of stimulated uninfected 
monocytes (Figure 6). This effect was observed foL all 
concentrations of pure IL-l used, ranging from 0.25 
U/ml to 2 0/ml. Addition of IL-l-containing supernatant 
from LPS-stimulated monocytes undiluted and at a 1:2 
and a 1$4 dilution, was able to restore the normal PHA 
response. At s 1:16 dilution, the response could not be 
fully restored. Proliferation at a 1:16 dilution was 
nevertheless significantly increased compared to levels 
in the presence of HCMV infected monocytes.
However, addition of varying dilutions of pure IL-l or 
IL-l-containing supernatants to unstimulated, 
HCMV-infected monocytes was unable to restore the 
proliferative response of autologous T lymphocytes to 
levels found in the presence of unstimulated, 
uninfected monocytes (Figure 7). This was observed for 
the equivalent concentrations of IL-l that were added 
to stimulated HCMV-infected monocytes.
3.5.0. Expression of HCMV IE Antigens in 
Differentiated and Undifferentiated ML-3 Cells
After treatment with PMA and infection with the Towne 
strain of HCMV, 10-12% of the cells were positive for 
IE proteins at 72h post infection (Figure 8). For 
undifferentiated cells infected with the Towne strain,
(.Ok« km 
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□  I  lymphocyltii and slrrKitcted. CMV-tNected inonocytes (tecsh isolate strom, 0006 PfU pet ce ll)
^  T tymphocvtei and MdtmicMKl. uniniected monocytes
■  !  ‘vmphocyt#*, s tm i laN kl CMV-tnJocted m onocyte* and pum M . w fw e the tiho l concenhation preparation wo* 2U/m6
Q  T h 'tn ^o cyte *. rtim u la ^d  CMV-tnletcted monocytes ceid fc-t contairm g iupem at<xil 
|2 |  7 h-mphocy^fS, *Wnuk3NKf itfWXecfed m oooc>iei and pun»
u -'rttu ted  *2 14 116
0HUI1QN O f INUfttiUKIN 1
Rgum#IBect at adtiHtoon of M  conl srwng siwmalant or pure on the PHAnndmed pfoHtenaiion al l tympfivxyfet m@ pwence 1 PS-ttlmutoNKl. CMV-tnkKtoo mr^ ccyWi Cutfure rfMana bom CMV*«^ ecMKa of unntected rr onocytn wwe amoved aDe M  days and replaced w#h fresh autologous T lymphocytes > (he peesence al vtwytng dUuhons ot H I containing supernatant or uitrapum IU1 N-.TTphocyte proteetation was atatmms 4 days kflw and (44) tnyrrticHne mcorporatton e*pre«ed as the mean opm o< tnpticate samples ± 1 SD
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□ I  lymphocytes ana unstimulalcd CMV-inlecled monocytes (clinical Isolate strain: 0005 PFU pet cell)
T lymphocytes and unshmuloted. unlntecled monocytes
I  lymphocytes, unrtlm ulrted, CMV-miecled monocytes and
pure ll-i where the initial concentration of me It I preparailon was 2U/mJ
I  lymphocytes, unstimuioled, CMV-lntected monocytes and 
IW containing supem ato*
T lymphocytes unslimulated. unmlected monocytes and pure IL4
r
undiluted i2  1:4
DtLUliON OF INTERLEUKIN 1
1:16
figure iESeci dt addition of i l l containing lupematant or pure H-t on the PHA-induced protiterat;on of 
I  lymphocytes m the presence of unstrnutated, CMV-intected monocytes Culture supernatants 
Horn CMV-intected or uninfected monocytes were removed after 3-4 days ana replaced with 
fresh autologous T lymphocytes in the presence of varying dilutions of M  containing 
supernatant or uHrapure il- l T lymphocyte prolteration was assessed 4 days later and (44) 
thymidine incorporation expressed cs the mean dpm of triplicate samples ±  1 SD.
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the percentage of cells positive for IB proteins was 
0-2% at 72h post Infection. Pre-treatment of ML-3 cells 
wl h PMA for 34h prior to BCMV challenge, with 
subsequent washing to remove PMA, achieved the same 
effect as the continued presence of PM' n the medium 
throughout tne 72h period after infection, ibis 
suggests that differentiation alone was responsible for 
Increased expression of HCMV IE antigens. Treatment of 
ML-3 cells with PMA after infection also resulted in a 
greatly reduced frequency of cells expressing IE 
antigens (0 - 2%) at 72h, suggesting that pretreatment, 
was essential for IB antigen expression.
3.6.0. HCMV Enhances Expression of Monocyte 
Inflammatory Mediator Genas In ML-3 Promyelocytes 
Following Induction of Differentiation by PMA
The results shown in Figure 9 indicate that ex? -sure of 
t'-e promyelocytic cell line, ML-3, to PMA prior to 
virus infection resulted in a high level of HCMV 
modulation of IL-1 ,TNF- end CSF-1, These three 
genes were all induced following PMA differentiation 
and their expression was further enhanced and sustained 
following HCMV infection. Within 24h of virus exposure, 
significantly higher lev Is of IL-1 , TNF and CSF-1 
steady state mRNA w't e observed in HCMV-lnfected cells 
compared to uninfected controls. These levels were 
sustained for the next 3 days after infection. In ML-3
110
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I n d ire c t  Immmo f lo u r  w a ne*  « t# ln in g  o f  HOIV IB an tigen
In ML-3 cells following PMA-induced differentiation*
(a) HCMV IE antigen flouresent staining of uninfected 
HL-3 cells following PMA-induced differentiation.
Celle were stained 3 days after mock-infection 
(SOOX)
!b) HCMV IB antigen expression in ML-3 cells following 
P MAilnduced differentiation. Cells were stained 3 
d ay# after infection (500:)
* Cells were counterstained with methyl red to reduce 
n o n - # p e c l f lc  floureeccnc*
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Northern transfer analysis demonstrating that HCMV 
infection modulates expression of IL-le, TNPa and 
CSF-1 in ML-3 cells
(a) induced to differentiate prior to HCMV challenge
(b) undifferentiated prior co challenge with HCMV
Autorads were exposed overnight for IL-1B, TNF@
CSF-1, lysozyme (LXS) and 8-actin in (a).
Exposure for LYS and 8-actin was overnight for (b) 
and 2 weeks for IL-18 in (b).
(+) HCMV infected 
(-) Uninfected controls
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cells that were undifferentiated prior to HCMV 
challenge, only the IL-16 gene could be detected at 
very low levels In Infected cells after a two week 
exposure of Northern blots (Figure 9B). C8P-1 and TNF-ot 
were not detectable after this exposure period.
Results for Northern blot analysis obtained with the 
cDMA clones are shown In Figure 10. The only one of 
these inflammatory response genes to behave in the same 
way as IL-S , TNFa and CSF-1 was NAD-9. Two days after 
infection enhanced levels of MAD-9 mRNA were still 
present in cells that were differentiated prior to 
infection by HCMV. Very low levels were detectable in 
uninduced ML-3 cells that were challenged with HCMV. 
PMA treatment of KL-3 cells did not result in i-duction 
of MAB-6 and MAD-2 mRHA and the expression of these 
genes was not enhanced and sustained after HCMV 
infection (Figure 10).
3.7.0. HCMV Dependent Enhancement Requires Induction 
of the Macrophage phenotype
The results depicted in Figure 11 indicate that 
induction of the macrophage pathway of differentiation 
was required for enhancement of IL-16 steady- -tate mRNA 
levels. The low but significant level of IL-16 mRNA at 
24h post infection, war markedly less than that 
observed in PMA-differentiated infected ML-3 cells at
II#
northern transfer a n a l y s i s  demonstrating t h a t  not a l l  
macrophage-associated i n f l a m m a t o r y  g e n e  e x p r e s s i o n  is 
u p - r e g u l a t e d  following ac*V c h a l l e n g e
Lanes (1) Human monocytes isolated by percoll gradient 
separation
( 2 )  t . c n o c y t e s  a d h e r e d  t o  p l a s t i c  f o r  3 0  minutes
( 3 )  ML-3 c e l l s  p r i o r  t o  P M A - in d u c e d  
d if fe r e n t ia t io n
( 4 )  M L -3 c e l l s  c u l t u r e d  w i t h  PMA f r 8 hours
(5) U n d i f f e r e n t i a t e d  M L -3 cells cultured for 2 
days after m o c k - l n f e c t i o n
(6! Undifferentiated M L - 3 cells cultured f o r  2 
days a f t e r  HCMV c h a l l e n g e
(7) P M t - d i f f e r e n t i a t e d  M L -3 cells cultured for 2 
days after m o c k - l n f e c t i o n
( 8 )  P M A - d i f f e r e n t l a t e d  M L -3 cells c u l t u r e d  f o r  2 
days after HCMV challenge
MAD-6
IL -1 jg
MAD-2
MAD** 9
FIGURE 10
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the same time point (Figure 11). Furthermore, this 
enhanced mRNA expression was not sustained in infected 
cells after 24h. By 72h post infection, the level of 
mRNA expression in infected cells had decreased and was 
comparable to that seen in uninfected cells. DMSO 
treatment resulted in depressed levels of lysozyme 
(LYS) mRNA at 72hr, but these were not further 
increased or decteased by virus exposure.
3.8.0. 8CMV Infection of Monocytes Results in 
Enhanced and Longterm Expression of XL-1b mRNA
Cytoplasmic "dot blot" analysis of IL-19 mRNA levels in 
HCMV-infected and uninfected peripheral blood monocytes 
at 24h# 4 8h and 72h post infection is shown in Figure 
12B and the densit .'trie analysis is shown in Figure 
12A. Monocytes cultured in the absence of LPS and mock 
infected with culture supernatant from uninfected 
fibroblasts gave only a weak transient signal, whereas 
LPS-scimulated mock infected monocytes gave a strong 
transient response that was still detectable at 48h. In 
contrast, BCMV infection of L»S-atimulated monocytes 
resulted in a more sustained response that continued 
for 96 hr. The combination of BCMV and LPS gave a 
transient response not unlike LPS alone# except that 
the plateau phase was significantly elevated.
11*
PMA DMSO2 ^ ^  72h"
-f- —  - f - ----- j_.
IL-ls 
mt&k* ^  LYS
1 2 3 4 S
n o m :  11
N orthern tr*n»f#r an*ly#l» showing Lh*t M L - 3 cmllm 
require different! itlon wit h  PMA rather ti.mn DMSO in 
order to expree* competence for HC M V  m o dulation of the 
IL - 1 6  remponee
(+) HC M V  infected 
(-) Uninfected
PM*-differentiated E C M V  infected ML-3 celle in lane 1 
wer e  ueed am a ruferencs
FIGURE 12
Total cytoplasmic dot-blot analysis of IL-18 mPNA 
expcessicn In monocytes. Denaitometric analysis (A) 
was derived from analysis of the dot blots in (8/ and 
is intended is «n approximation of the kinetics of 
the response rather than an eAact quantitation.
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In situ hybridization analysis to resolve IL-1 irRNA 
expression in HCMV-infected and uninfected monocytes at 
the single cell level is depicted in Figure? 13 and 14. 
Data from 3 different donors is shown in Figure 13, as 
donor variations in levels of il-1 mRNA expression 
were observed at the more sensitive single cell level. 
For all three donors however, it was observed t h a t  HCMV 
i n f e c t i o n  always had the same effect on IL-1 mRNA 
exprecsion. The p e r c e n t a g e  of positive cells at 1, 2 
and 4 days post infection was consistently higher in 
infected monocytes than in mock infected controls. For 
all donors, HCMV infection resulted ir a small 
p e r c e n t a g e  of monocytes (1 - 8*) showing high l e v e l s  of 
IL-1 mRNA e x p r e s s i o n  (> 100 g r a i n s / c e l l  f o r  donor 2 
and >200 g r a i n s / c e l l  for donor 1 (Figure 14) a n d  donor 
3! which w a s  s u s t a i n e d  for up to 4 days p o s t - i n f e c t i o n  
(Figures 13 and 14). T h e r e  was no d i f f e r e n c e  in l„-l 
mRNA e x p r e s s i o n  l e v e l s  in u n a t i m u l a t e d  v e r s u s  
L P S - s t i m u l a t e d  m o n o c y te s  (data shown for d o n o r  2 o n l y ) .
1.9.0. HCMV Dependent Enhancement of IL-1 mRNA 
Levels Loads to Transiently Enha- ed Translation of 
IL-1
in the f i r s t  s t u d y  t h a t  was c a r r i e d  out to d e t e r m i n e  if 
the e n h a n c e d  l e v e l s  o f  s t e a d y  stake IL-1 mRNA were a 
r e f l e c t i o n  of e n h a n c e d  translation of this i m p o r t a n t  
m e d ia t o r  g e n e ,  flow cytometric analysis d e m o n s t r a t e d  
that a l t h o u g h  pma t r e a t m e n t  alone lead to e x p r e s s i o n  o f  
protein, exposure to HCMV following induction of
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IL-l 1 mRMA expression In HCHV Infected and uninfected 
monocytes analysed by 111 situ hybridization. Monocytes 
from three different donors were analysed for IL-18 
mRRA expression 1,2 and « days after infection u s in g  a  
^5S-labelled IL-Ie anti-sense RNA probe. Background 
staining was revealed by hybridizing cells to 
35S-labelled IL-18 sense RNA sequences (A) for each 
donor. Numbers of positive cells and grain counts w e r e  
determined by evaluating approximately 200 cells/slide.
(v-) uninfected 
(v+) HCMV infected
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u s m m
IS, #it* hybtldleatlon enelysis of It-18 BRSk exptession 
In monocytes from Donor 1. B O W  Infected (v+) or 
uninfected (v-) monocytes were cultured for up to 4 
days poet-lnfection. At 1,2 and 4 days, 14A.B and C 
respectively, cells were hybridised with a 
^*3-labelled anti-sense RMA probe specific for TL-lfl. 
Arrows Indicate cells chronically expressing IL-18 
mRNA. Control hybridizations were performed with a 
sense IL-1B probe (14D),
U22SI-
UGORE H B
FIGURE 14C
FIGURE 14D
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differentiation (Figure 15) lead to a marked increase 
in the anount of cell associated intracellular IL-18 
24hr aftor infection. At later time points (72 hr after 
infection*, no intracellular 1--1B was detectable. The 
isotype control monoclonal antibody that was u td (Leu 
2A) gave similar levels of flouresence on both cell 
preparations. HCMV- infected cells had the same levels 
of floucesenc-s as controls (data not shown).
Staining for the presence of intracellular IL-18 in 
peripheral blood monocytes is shown in Figure 16. At Id 
post infection, the majority of monocytes in both 
infected and uninfected cultures were positive for 
intracellular IL-16. However, in the infected cultures 
there was a subpopuiation of cells showing high IL-18 
levels, as was observed Zor mRNA expression at the 
single cell level. At 2d post infection there was a 
decrease in the number of IL-18 positive ce'Us, as 
well as a decrease in IL-18 levels. By 96h post 
infection intracellular IL-18 was longer detachable.
To confirm the presence of intracellular IL-16 protein 
and to compare responses in ML-3 cells and monocytes. 
Western blotting analysis was performed, the results of 
which are shown in Figure 17 . In both cell types the 
intraceiluiar form of 1L-1B was only detected at 24 hr 
post-infection, indicating that sustained expression 
did not neccessarily lead to continued translation.
IN
hunow im itn ctus
a-i
IBM*
FLUORESCENCE
FIGURE 15
Flow cytometric analysis ot Intracellular IL-1B 
expression in PMA differentiated ML-3 cells with ot 
without HCMV 24 hr after infection. Both the IL-16 
monoclonal antibody and the Leu-2a control are igGl 
subclass.
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Pi@m: w
Indirect iroanopetoKldaie staining of call associated 
IL-1 I in uninfected and HCMV-infected monocyte* at- 1 
(16*) and 4 (168) days after Infection. Arrows indicate 
positive cells.
(v-) uninfected 
(»+) HCMV infected

FIGURE 16B
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FIGURE 17
Western blotting analysis of cell associated IL-la 
translation products in monocytes and ML-3 cells. 1-5 
(monocytes) and (6-11) ML-3 cells.
1 - Uninfected monocytes cultured for 24hr
2 - Monocytes infected with heat-inactivated virus
24hr after infection
3 - HCWV infected monocytes 24hr after infection
4 - Monocytes infected with heat-inactivated virus
72hr after infection
6 - BCMV infected monocytes 72hr after infection
7 - PMA treated ML-3 cells cultured for 24hr
8 - PMA treated ML-3 cells infected with
heat-inactivated virus 24br after infection
9 - HCWV infected PMA treated ML-3 cells 24hr after
infection
10 -PMA treated ML-3 cells infected with
heat-inactivated virus 72hr after infection
11 -HCMV infected PMA treated ML-3 cells 72hr after
infection
* The blot was cut into individual strips to be 
developed, hence the overlapping of lanes in the 
photograph.
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Unstimulated, mock infected monocytes cultured for 24h 
post infection showed, as expected, no pro-lL-lB 
protein production. HCMV infected rr.onocytas, however, 
showed a significant level of the intracellular form of 
pro-IL-lB protein at 24h post infection. No activity 
was detected in uninfected or infected monocytes at 72h 
post infection. For ML-3 cells, only PMA-induced cells 
that had been infected with HCMV gave a detectable 
signal at 24h post infection.
Results in Figure 18 show that supernatants from HCMV 
infected unstimulated monocytes, at 24h post infection, 
contained significantly higher levels of secreted IL-lB 
than supernatants from uninfected unstimulated 
monocytes. The marked increase in intracellular IL-10 
that was observed by Western blot analysis and 
monoclonal antibody staining was reflected in increased 
secretion of IL-iB up to 48 hr post infection. However, 
for LPS-stimulated monocytes, levels of secreted IL-iB 
were significantly lower in supernatants of infected 
monocytes compared to uninfected monocytes.
3.10.0. The Immediate-Early Gene of HCMV 
Transactivates the I&-18 Promoter in PMA Treated Calls
To examine the possibility that enhanced expression of 
IL-18 seen in ML-3 cells could result from 
transactivation of the IL-18 gene by HCMV IE gene
FIGURE 18
Quantitative measurement of IL-1 levels in 
supernatants from LPS-stimulcted and unstimulated 
CHV~infected or uninfected monocytes. Supernatants from 
uninfected (-) and CMV-infected ( + ) monocytes were 
removed Id after infection (1- and 1+) and replaced 
with fresh medium. Supernatants were removed after a 
further 24h (2- and 2+) and replaced with fref Tedium. 
After a further 48hr supernatants were removed again 
(4- and 4+1.
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products, chimeric plasmids containing proIL-1 
sequences fused to the CAT gene were co-transtected 
into undifferentiated and PMA-difterentiated ML-*3 cells 
with various HCMV I is gene region plasmid constructs.
The data in Figure 19 ^hows the effect of the HCMV IE 
gene region when tested in cotransfection experiments 
with the positive control plasmid 3MB-AT, The HCMV IE 
gene region plasmid contained both regions 1 and 2 of 
the IB coding sequences. In PMA-differentiated cells, 
increasing additions of the IE gene region DMA led to a 
marked expression of CAT activity. Co-transfection with 
10v*g each of plasmid pHDlOlSVl and 3ME-AT DMA gave 
maximum activity in the dose response as shown in 
Figure 19. In undifferentiated ML-3 cells there was no 
trans-activation of the IL-18 gene by the HCMV IE gene 
region. The apparent requirement for differentiation 
suggests the need for a host tierWed competence factor 
that appears to be derived from PMA stimulation.
To confirm that the trans-activation of the IL-16 gene 
by HCMV IE gene products was not due to an enhancing 
effect of the 9V4Q ennancer located adjacent to the 
SV40 promoter in plasmid 3ME-AT, HJMV IE region gene 
constructs were co-transfected into ML-3 cells with 
plasmid 3M-AT. Results in Figure 20 show the effect of 
HCMV IE region expression plasmids on IL-S promoter 
function in ML-3 cells that were induced to 
differentiate with PMA prior to transfection. When
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Effect of HCMV IE region gene products on the IL-1P 
gene in undifferentiated and PMA-differentiated ML-3 
cells, Cells were cotransfected with the positive 
control IL-16-CAT plasmid DMA (3ME-AT) and pHDlOlSVl 
coding for regions 1 and 2 of the HCMV IB region. CAT 
activity was assayed for 48hr after transfection.
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FIGURE 20
Effect of HCMV IE gene products on the I L - 1 8  gene in 
undifferentiated (B ) and PMA-differentiated (A) ML-3 
cells. Cells were cotransfected with IL-1B -CAT plasmid 
DMA (3M-AT) and HCMV IE gene region plasmids, pHDlGlSVl 
containing regions 1 and 2, pHD101SV2 containing region
1 only or 10142 containing region 2 only. CAT activity 
was assayed for 48hr after transfection.
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3M-AT DNft was transfected singly into 
PMA-diffecentiated ML-3 cells there was no CAT 
activity. When plasmid 3M-AT containing 524 bp of 
pro-IL-16 genomic DMA was cotransfected with the HCMV 
XI reyicn 1 and 2 expression plasmid, pHDlOlSVl, there 
was stimulation of activity of the IL-18 promoter as 
judged by CAT activity (Figure 20). To ascertain 
whether regions 1 and 2 of the HCMV IB region were both 
required for transactivation of 3M-AT, HCMV plasmids 
encoding either region 1 or region 2 were cotransfected 
with 3M-VT. The region 1 products alone (pHD10lSV2) do 
not support IL-18 promoter activity (Figure 20A). In 
contrast, region 2 products resulted in activity 
equivalent to that obtained with regions 1 and 2 
together. Figure 20B shows that cotransfection 
experiments in ML-3 cells that were not induced to 
differentiate prior to transfecttion, resulted in no 
stimulation of IL-18 promoter activity.
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4.0.0. DISCUSSION
In this study the functional effect of HCMV infection 
on production of IL-1 activity was investigated in 
both unstimulated and LPS-etimulated monocytes in an 
attempt to eximine more closely the mechanisms f 
immunosuppression that may accompany HCMV infe ion in 
vivo. Previous reports have described effects of HCMV 
infection on unstimulated monocytes only.
&t a functional level, infection of monocytes with 
laboratory-adapted strains and clinical isolates of 
HCMV were also compared, as previous reports had 
described biological differences between such strains 
with regard to degree of infection of peripheral blood 
mononuclear cells (Rice et al., 1984; Binhorn and Oat, 
1984). Results obtained in this study confirmed that 
strains 4D169 and Towns failed to initiate expression 
of detectable immediate early antigen in the majority 
of infected monocytes even when these cells were 
stimulated with LPS (Table 2). However, a small 
fraction of monocytes infected with the clinical 
isolate of HCMV expressed IE antigen (figure 4) with 
the percentage of apparently infected cells rising with 
Increasing MOI (Table 2).
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h possible explanation for the detection of viral 
antigens or genes in such a limited proportion of cells 
is that immunological and molecular biological probes 
studied and used to date might not be able to detect 
latent HCMV infection at a sensitive enough level. 
Monoclonal antibodies for detection of HCMV IB antigens 
enable detection of region 1 and 2 gene products 
collectively, but not independent of one another.
Recent studies by several different investigators h?ve 
proposed that the HCMV IE region 2 gene products are 
involved in the regulation of viral or host cell 
promoters, either independently or in combination with 
HCMV IB region 1 gene products (Hermiston et al., 1987; 
Pizzorno et^  al., 1988). Gene amplification experiments 
using probes for specific IB region gene products will 
allow for an inveotjgation of this phenomenon.
In addition to their effector role, monocytes play an 
essential cole in the initiation of immune responses 
through antigen presentation and production of IL-1. 
impairment of these accessory functions could be a 
major factor in the im-unosuppression that is 
associated with HCMV infection. Changes in IL-1 
regulation could contribute to the pathology of the 
infection. The investigation in this study into the 
role of monocyte infection in T lymphocyte responses to 
mitogens showed that virus-challenged monocytes were 
suppressive for T cell blastogenesis. LPS-stimulated
H?
monocytes challenged with either strain of HCMV were 
mote suppcessive foe autologous T lymphocyte responses 
than were virus-challenged unstimulated monocytes when 
tested under identical assay conditions (Table 3).
Stimulated monocytes pinduce significantly higher 
levels of functional IL-1 activity than do unstimulated 
monocytes, but virus infectioa abrogated production of 
functional IL-1 bioactivity, as assessed by the mouse 
thymocyte bioasray with monocyte-conditioned medium 
(Figure 5). Monocytes infected with the clinical 
isolate were more suppressive than AD169 infected 
monocytes, with a MOI of 0.005 and 5 PPU/cell, 
respectively, resulting in a similar abrogation of 
released IL-1 activity (Figure 5).
The next stage in this study sought to determine 
whether the decrease in production of IL-1 bioactivity 
by HCMV-infected monocytes was contributing to the 
suppression of T cell proliferative responses.
Exogenous IL-1 was therefore added tr HCMV infected 
monocytes to determine whether this impaired accessory 
cell function could be reconstituted. Addition of 
supernatant containing IL-1 from LPS-stimulated 
monocytes or of ultrapure IL-1, fully restored the 
proliferative response of T cells cultured in the 
presence of stimulated HCMV-infected monocytes to that 
observed in the presence of control monocytes (Figure 
6). In contrast, however, addition of IL-1 to T cells
U8
cultured with unetimulated HCMV-infected monocytes did 
not restore proliferation (Figure 7), a result 
suggesting that unstimulated, HCMV-infected monocytes 
release functional IL-1 inhibitory activity. To assess 
whether unstimulated, infected monocytes were in fact 
releasing IL-1 activity that was being masked by the 
concomitant production of functional il-1 inhibitory 
activity in the mouse thymocyte bioassay, quantitative 
measurements of IL-1 levels were made using ELISA 
*###**.
Supernatants from Infected stimulated monocytes 
contained significantly less secreted IL-1 actl-ity 
t u n  uninfected stimulated monocytes (Figure 18), which 
suggested that the decreased proliferation of mouse 
thymocytes was not due to inhibitory activity masking 
release of functional IL-1 . Also, the observation that 
normal T cell proliferative responses could be 
reconstituted by addition of exogenous IL-1 to 
stimulated, infected monocytes further substantiates 
the observation that suppression of lymphocyte 
responses by stimulated infected monocytes was not due 
to release of IL-1 inhibitory activity. However, in the 
unstimulated system, supernatants from infected 
monocytes contained increased amounts of IL-1 compared 
with those of controls (Figure 18) at 24h and 48h 
pORt-infection. The functional activity of this IL-1 
could not be detected In the mouse thymocyte
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proliferation assays, suggesting that IL-1 inhibitory 
activity was being concomitantly released. The release 
of IL-1 inhibitory factors by unstimulated, infected 
monocytes also explains the inability to reconstitute 
the PHA-induced proliferative response of T lymphocytes 
by addition of exogenous IL-1.
In an earlier study of HCMV-mediated immunosuppression, 
Carney and Hirsch (1981) showed that monocytes from 
HCMV-infected patients as well as monocytes infected in 
vitro inhibited the con A -induced proliferation of 
lymphocytes in subsequent culture. Rodgers et, al.
(1985) proposed that HCMV-infected unstimulated 
monocytes were defective in IL-1 production. They 
associated this with the release of a monocyte-derived 
inhibitor of IL-1. However, a subsequent report by 
Scott et al, (1989) has suggested that this inhibitory 
activity was due to mycoplasma contamination of the 
cell lines used.
Although the possibility exists that the stocks of 
strain AD169 used in the functional studies reported in 
Budding and Garnett (1987), were contaminated with 
mycop asma, the clinical isolate was passaged directly 
from a patient into HELs that were rigorously checked 
for mycoplasma. Furthermore, at a functional level, the 
clinical isolate had a greater immunosuppressive effect 
than strain AD169. The above observations (Budding and 
Garnett, 1987) have since been corroborated by others.
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Kapasi and Rice (1988), using stocks of Towns strain 
that were passaged in mycoplasma-free cell lines found 
that prior infection of either monocytes or lymphocytes 
with HCMV in vitro followed by reconstitution with 
uninfected lymphocytes or monocyces respectively, 
abrogated the proliferative response of lymphocytes to 
PH A in subsequent culture. Infection of either cell 
type reduced IL-1 and IL-2 production. Normal 
proliferative responses of lymphocytes cultured in the 
presence of unstimulated infected monocytes could 
similarly not be reconstituted by exogenously supplied 
IL-1 or IL-2. Their data suggested that decreased 
proliferative responses of PBMC were not solely due to 
decreased IL-1 production or production of IL-1 
inhibitors, as PBMC should have responded to IL-2, 
which they did not. Furthermore, no evidence of an IL-2 
inhibitor was found. A generalised metabolic depression 
of PBMC activity was proposed.
Further support for results obtained in this study is 
found in other virus systems. Roberts et al. (1986) 
showed that IL-1 inhibitors were produced concomitantly 
with substantial. IL-1 activity by influenza and 
respiratory syncitial virus (RSV) infected monocytes. 
Much attention has recently been focused on IL-1 
production by HIV-infected monocytes, in view of the 
fact that monocytes can be infected by HIV and that 
impairment of monocyte accessory cell functions could
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be a major factor in the immune deficiency and 
pathogenesis of AIDS. Findings for il-1 proc action by 
HIV-infected monocytes have been similar to those 
reported in this study. Berman et al. (1987) examined 
monocyte production of IL-1 activity from yatients with 
AIDS and quantitated production of endogenous 
macrophage-derived IL-1 inhibitors. Culture 
supernatants from unstimulated peripheral blood 
monocytes were fractionated to assess spontaneous IL-1 
release. PBMCs from patients with AIDS produced 
increased amounts of IL-1 activity compared with those 
of controls, together with marked increases in factors 
which inhibited this functional IL-1 activity, as 
assessed in the mouse thymocyte proliferation assay.
Enk et ajl. (1986) found depression of T lymphocyte 
responsiveness to IL-1, but enhanced production of 
IL-1. Roux-Lombard et ai, (1989) measured production of 
IL-1 and TNF in supernatants of monocytes obtained 
from HIV 1-infected patients that had been cultured in 
vitro for 18h. IL-1 levels were elevated in 
symptomatic patients compared with controls and 
intermediate in asymptomatic HIV 1-infected 
individuals.
The inhibitory factors produced by unstimulated 
HCMV-infected monocytes in this study and by 
HIV-infected monocytes are perhaps common endogenous 
mediators of virus-inducad immunosuppression which are 
present in healthy individuals but increased in
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infection. Larrick (1989) proposes that these 
macrophage-derived inhibitors associated with viral 
infections are likely to contribute to the pathogenesis 
of the disease either by direct inhibition of IL-1 
secretion or by binding to receptor sites on IL-3 
responsive cells, thereby interfering with accessory 
functions of IL-1,
Ac the molecular level, experiments done to assess the 
effect of HCNV infection on steady state IL-1B mRNA 
expression showed that HCMV infection of monocytes 
resulted in enhanced and long-term expression of steady 
state IL-1B mRNA. Dot blot analysis of total 
cytoplasmic RNA (Figure 12) showed that monocytes 
cultured in the absence of LPS gave only a weak 
transient signal, whereras LPS addition stimulated a 
string transient response that was weakly detectable at 
24 to 48hr. Similar kinetics have been described by 
Fenton et al. (1987), In contrast, HCMV exposure 
resulted in a more sustained response that continued 
for 96hr. The combination of HCMV and LPS gave a 
transient response, not unlike LPS alone, except that 
the plateau phase was significantly elevated.
In order to assess if these enhanced levels of 
steady-state IL-IB mRNA were aue to increased 
expression by the entire population of monocytes or a 
certain fraction only, in situ hybridization was vseJ
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